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Chemicat substances and Drugs
lfenprodil tartrate: (1 RS, 2SR)-4-[2-(Benzylpiperidin-1-yl)-1-hydroxypropyl]phenolhemi-(2R,3R)-tartrate
MK--801: (5R,10S)-(+)-5-MethyJ-10,11-djhydro-5H-djbenzo[a,d] cyclohepten-5, 10-imine hydrogen
maleate
Neurotransmitters
DA: Dopamine
Brain Regions
VTA: Ventral tegmental area
Buffers
DMEM: Dulbecco's modified Eagle medium
KRB: Krebs-Ringer bicarbonate buffer
PBS: Phosphate buffered saline
Endogenous substances
AADC: L-amino-aromatic acid decarboxylase
cAMP: cyclic adenosine monophosphate
CaMKIt: Ca2'/Calmodulin-dependent protein kinase ft
Ca.1 .2: od c subunit
Ca.1 .3: od d subunit
CREB: cAMP response element binding protein
DAT: dopamine transporter
DRs: dopamine receptors
DiDRs and D2DRs: dopamine Dl and D2 receptors
NMDA: N-methyl-D-aspartate
TH: tyrosine hydroxylase
PKA: cAMP-protein kinase A
RyR: Ryanodine receptor
VGCCs: Voltage-gated Ca2' channels
lnjection route
i.c.v.: lntracerebroventricular
s.c.: Subcutaneous
i
Others
ANOVA: Analysis of variance
CNS: central nervous system
CPP: conditioned place preference
CICR: Ca2'-induced Ca2' release
lgG: lmmunoglobulin G
mRNA: Messenger ribonucleic acid
PCR: Polymerase chain reaction
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                           General lntroduction
Ryanodine receptors
   Ryanodine receptors (RyRs) are located in the sarcoplasmic/endoplasmic reticulum
membrane and are responsible for Ca2' release from intracellular stores. RyRs are
classified as a family of large, homotetrameric intracellular Ca2" release channels that
allow rapid release of Ca2' from sarcoplasmic/endoplasmic reticulum stores into the
cytosol upon their activationi) and divided into three known mammalian isoforms of RyRs,
RyR-1, RyR-2, and RyR-3, that exhibit subtype-specific tissue expression patterns.
RyR-1 was first detected in skeletal muscle,2) RyR-2 was found in cardiac muscles, and
RyR-33), previously referred to as the brain isofrom4), was found in brain. These three
RyR subtypes exhibit a high degree of structural and founctional homology. Each
monomer is in excess of 560 Kd with the -•90 O/o of in the channel sequence comprising
enormous cytosolic domainst). A variety of physiological stimuli produces their
intracellular effects by increasing intracellular free calcium concentration5) and such
elevation of calcium concentration can be elicited by, at least, two different pathways, one
is the release of Ca2' from intracellular stores and the other is the promoting Ca2' entry
from extracellular space. Ca2'-induced Ca2' release (CICR) is an intriguing mechanism
found in many excitable cells that employs these two pathway5). All of these three
isoforms exhibit a biphasic response to free Ca2' and can participate in CICR.
   The RyR-1 is predominantly expressed in skeletal muscles2) and is located in the
junctional region of the terminal sarcoplasmic reticulum6). RyR-1 also appears to be
expressed at low levels in cardiac muscle, smooth muscle, stomach, kidney, thymus7),
cerebeilum, Purkinje cells, adrenal glands8År. RyR-2 is expressed at high levels in
Purkinje cells of cerebellum and cerebral cortex9'iO). RyR-3 is expressed in hippocampal
neurons, thalamus, Purkinje cells, corpus striatum4), and skeletal muscles.
   Mutations in both RyR-1 and RyR-2 are associated with a number of human diseases.
Mutations in RyR-1 gene underlie several debilitating and/or life-threatening muscle
diSeases including malignant hyperthermia, heat/exercise induced exertional
rhabdomyolsis, central core disease, multiminicore diseaseii).
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Rewarding property of conditioned place preference paradigm
  Conditioned place preference (CPP) procedure is used to evaluate motivational
properties such as rewarding or aversive properties of drugs including morphine,
methamphetamine (METH), and cocaine. CPP paradigm has become the most frequently
used method to assess drug-induced motivational effects. In this procedure, the
association that develops between the presentation of a drug and a previously conditioned
stimulus (e.g., differently colored compartment of a shuttle-box) can be evaluated.
Rewarding effects of drugs are measured in animals that are drug-free. Thus, any
changes in unconditioned motor activity do not directly influence the development variable.
In general, rewarding effects of drugs can be assessed more quickly than with other
operant paradigms such as self-administration. In addition to providing information on
the rewarding properties of drugs, CPP paradigm also enables detection of aversive
properties of drugsi2).
Implication of the mesolimbic dopamine system and glutamate receptors in the
rewarding effect
   Drugs of abuse produce their reinforcing effects through actions in the limbic
component of the basal ganglia, a circuit of nuclei that is responsible for the influence of
motivational, emotional, contextual and affective information on behaviori3).
   The mesolimbic dopaminergic pathway, which originates from the ventral tegmental
area (VTA) and projects to the nucleus accumbens, amygdale, and prefrontal cortex plays
an essential role in the development of rewarding effect of METH and cocainei4'i5).
   In the VTA, ehhanced actMty of dopamine neurons is an essential step for consequent
behavioral change. Furthermore, the dopamine Dl receptors (DIDRs) and
N-methyl-D-aspatate (NMDA) that are known to modulate VTA dopamine activity, may
affect the severity of rewarding effect of METHd6'i7År. In addition to dopamine,
giutamate-dependent cellular mechanism is involved in neuroadaptative processes of drug
addiction. In particular, this is true in regard to drug-associated learning and memoryi8).
Glutamatergic neurons projected predominantly from the prefrontal cortex and other limbic
regions innervate to the VTA to drives dopaminergic neuronal activity and to nucleus
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accumbens to modulate the neuronal activity of dopamineceptive neurons via released
glutamate. The requirement of glutamate to activate midbrain dopamine transmission led
to the findings that long-term potentiation could be formed in both VTA dopamine neurons
and median spiny neuron in the nucleus accumbensi9}.
   Glutamate receptors have been divided into NMDA receptors and non-NMDA receptors
based on their pharmacological properties. The molecular cloning of NMDA receptors
has identified a variety of NMDA receptor subunits, common NRI subunit and four distinct
NR2 (NR2A, NR2B, NR2C and NR2D) subunits. NMDA receptors are heteromeric
ligand-gated ion channel that interacts with multiple intracellular proteins. The obligatory
NRt subunits form ion channels and multiple NR2 subunits regulate the properties of the
channe120). Recent behavioral studies have revealed that NMDA receptors are involved in
the development of rewarding effect by chronic administration of METH2i).
L-type voltage-dependence Ca2' channels
  Voltage-gated calcium channels (VGCCs) are large family of integral membrane
proteins that control selective flow of Ca2' against their electrochemical gradient in
response to depolarized changes in membrane potential and forms heteromeric complexes
consisting of cti, ct2, P, 6, and y subunits22). Especially, L-type VGCCs (ctic and ctid
subunits from Ca.1.2 and Ca.1.3 channels, respectively) show electrophysiological and
pharmacological diversity23). ctic and ctid subunits forming Cavl.2 and Cavl.3 channels,
respectively, are dominant calcium channel-forming subunits of L-type VGCCs. These
channels are expressed in many types of neurons and are located in the soma, proximai
dendrites, and postsynaptic regions of neurons24). In the nervous system, Cavl channels
conduct L-type Ca2' currents that dualiy regulate membrane excitability and intracellular
signal transduction25). previous investigations report that chronic treatment with
morphine induces upregulation of ctic and ctid subunits26) and that rewarding effect of
morphine is reduced by nifedipine27). These data suggest that ctic and ctid subunits of
L-type VGCCs participate in the development of rewarding effect.
3
                              Aim and Scope
  The aim of the present study is to investigate the involvement of ryanodine receptors in
the development of methamphetamine (METH) - and cocaine-induced place preference
using behavioral, neurochemical and biochemical experiments.
The specific aims of the proposed research are:
ln Chapter 1:
   ln order to examine which isoforms of ryanodine receptors change in animal special
brain regions, the frontal cortex and limbic forebrain predominantly including the nucleus
accumbens, after the development of psychological dependence on METH, l investigated
whether RyRs were involved in the development of the METH-induced place preference by
using a conditioned place preference paradigm.
In Chapter 2:
   ln order to clarify the mechanisms to regulate the expression of RyRs, 1 investigated
whether in vitro treatment with METH was able to affect the expression of RyRs in primary
cultures of midbrain and cerebral cortical neurons from mice. In addition, as dopamine
plays an important role in neuronal functions controlled by mesolimbic dopaminergic
neurons, 1 also examined how dopaminergic receptors in these neurons in primary culture
participate in RyR expression.
In Chapter 3:
   ln order to examine roles of NMDA receptors in RyR expression in the ventral
tegmental area, l investigated whether antagonists for NR2B subunit-containjng NMDA
receptors suppressed the expression of RyRs in the brains of mice showing
METH-induced place preference.
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In Chapter 4:
   ln order to examine which types of RyRs are involved in the development of
cocaine-induced place preference, 1 investigated how expression of isoforms of RyRs
changes in the brain regions, the frontal cortex and limbic forebrain predominantly
including the nucleus accumbens, of mice with cocaine-induced place preference and how
dopamine receptors modify the changes in RyR expression in cocaine-induced piace
preference.
 In Chapter 5:
   ln order to clarify the mechanisms to regulation of expression of RyRs under the
presence of cocaine, 1 investigated whether in vitro exposure of cerebral cortical neurons
in primary culture to cocaine with or without presence of dopamine receptor ligands
affected the expression of RyRs.
5
Ethics
  The experiments using mice in the present study were approved by the Animal
Research Committee of Kawasaki Medical School and conducted according to the
" Guideline for the Care and Use of Laboratory Animals" of Kawasaki Medical School based
on the National lnstitute of Health Guide for the Care and Use of Laboratory Animals (NIH
Publications No. 80-23), revised 1996. All efforts were made to minimize animal suffering,
to reduce the number of animals used, and to utilize alternatives for the in vivo techniques,
if available.
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Chapter 1
Regulation of ryanodine receptors by
methamphetamine-induced place conditioning
dopamine Dl receptors during
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                              lntroduction
   METH is strong addictive psychostimulants that dramatically alter functions of the CNS.
Abuse of psychostimulants leads to the development of psychotic symptoms similar to
those of paranoid schizophrenia. A growing body of evidence suggests that the
mesolimbic dopamine system, which originates in the VTA and mainly projects to the
nucleus accumbens and the medial prefrontal cortex, plays an important role in the
development of dependence on psychostimulants28•29).
   Among the factors involving in the development of psychostimulant dependence, Ca2'
influx via L-type VGCCs have been reported to be necessary for psychostimulant-induced
behavioral and neurochemical changes30-32). Previous study demonstrated that blockers
of L-type VGCCs inhibit the development of psychological dependence on drug of abuse27)
and therefore the up-regulation of L-type VGCCs (Ca,1.2 and Ca,1.3 channels) may have
a crucial role in the development of psychological dependence.
  Among the mechanisms that regulate intracellular Ca2' concentration by functionally
coupting to L-type VGCCs are RyRs33'34), which is present on endoplasmic reticulum and
release Ca2' from intracellular Ca2' stores in response to a variety of stimuli including
intracellular local accumulation of Ca2' via L-type VGCCs. RyRs are activated by Ca2' in
a process of CICR, as well as by a change in membrane voltagei'35). However, little is
known about the role of RyRs and L•-type VGCCs and their relationship in psychological
dependence on METH. 1 have therefore examined in this study whether whether both
RyRs and L-type VGCCs participate in the development of the METH-induced place
preference by using a conditioned place preference paradigm.
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MATERIALS AND METHODS
Animals
  The present study used male ddY mice (8 week old; Japan SLC, lnc., Hamamatsu,
Japan), which were housed in a room maintained at 22 Å} 1 eC, 55 Å} O.5 O/o with a 12 h
light/dark cycle for at least one week (light on 8:OO A.M. to 8:OO P.M.) before experimental
use. A total of 280 mice were used for this study. Food and water were available ad
Iibitum.
Intracerebroventricular injection
lntracerebroventricular (i.c.v.) administration was carried as described previously 36). The
mice were lightly anesthetized with diethyl ether and a 2 mm double-needle (tip; 27 G x 2
mm and base; 22 G xlO mm: Natsume Seisakusho Co. Ltd., Tokyo, Japan) attached to
25-pt1 Hamilton microsyringe was inserted into the unilateral injection site. Repeated i.c.v.
injection of nifedipine, dantrolene, SCH23390 and sulpiride were made into the same site
using a small guide hole that was made in the skull two days before the first injection.
The volume of drug solution injected was 4 pt1/mouse.
Place Conditioning
  Place conditioning studies were conducted using an apparatus consisting of a shuttle
box (15.5 x 35 x 17 cm, width x length x height), which was made of acrylic resin board and
divided into two equal-sized compartments. One compartment was white with a textured
floor and the other was black with a smooth floor to create equally inviting compartments.
The conditioning place preference schedule consisted of three phases (preconditioning test,
conditioning, and postconditioning test). The preconditioning test was performed as follows:
the partition separating the two compartments was raised to 7 cm above the floor, a neutral
PlatfOrm was inserted along the seam separating the compartments, and animals that had
nOt been treated with either drugs or saline were then placed on the platform. The time
SPent in each compartment during a 900-s session was recorded automatically using an
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infrared beam sensor (BS-CPP-MS; BrainSienceldea, Co., Ltd. Osaka, Japan).
Conditioning sessions (3 days for METH, 3 days for saline) were conducted once daily for 6
days. Immediately after METH injection, these animals were placed in the compartment
opposite that in which they had spent the most time in the preconditioning test for 1 h. On
alternative days, these animals received saline and were placed in the other compartment
for 1 h. On the day after the final conditioning session, a postconditioning test that was
identical to the preconditioning test was preformed. The preference for the drug-paired
place is expressed as the mean difference between the times spent during the
postconditioning and preconditioning tests.
   Animals in saline group were s.c. injected saline alone for 6 consecutive days,
whereas mice in METH group were administered METH every two days with saline
injection on the days when METH was not administered.
  Either vehicle, dantrolene (a non-selective inhibitor for RyRs; 1, 3, 10 nmol/mouse),
nifedipine (L-type VGCCs antagonist; 3, 10, 30 nmol/mouse), SCH23390 (a DIDR
antagonist; 3, 10, 30 nmol/mouse) or sulpiride (a D2DR antagonist; 3, 10, 30 nmol/mouse)
was i.c.v. administered 30 min before s.c. treatment with METH (4 mg/kg, s.c.) or saline.
Western blotting
  lmmediately after the post-conditioning test, mice were decapitated, and the frontal
cortex and limbic forebrain (containing the nucleus accumbens) were quickly dissected on
an ice-cold metal place. The dissected brain tissues were homogenized in ice-cold lysis
buffer containing 10 mM Tris-HCI (pH 7.5), 150 mM NaCl, O.5mM EDTA, 10 mM NaF, and
O.5 O/o Triton X-100 with a protease-inhibitor cocktail (Roche Diagnostics, lndianapolis,
USA). The homogenate was centrifuged at 1,OOO xg for 10 min and the resultant
supernatant was centrifuged at 1OO,OOO xg for 60 min at 4 eC.
   Protein samples (5 pg protein applied onto each lane) were separated by 3-80/o
Tris-acetate gel (lnvitrogen, Carlsbad, USA) and then transferred to nitrocellulose
membranes in Tris-glycine buffer. For immunoblot detection, the membrane was
incubated overnight at 4 "C with primary antibodies against od c (rabbit polyclonal anti•-od c,
1:tOOO; Alomone Labs Ltd., Jerusalem, lsrael:), odd (rabbit polyclonal anti-odd, 1:looO;
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Alomone Labs Ltd., Jerusalem, lsrael), ryanodine receptor type-1 (RyRs 1: mouse
monoclonal anti-ryanodine receptor type-1, Sigma-Aldrich, St. Louis, USA), ryanodine
receptor type-2 (RyRs 2: mouse monoclonal anti-ryanodine receptor type-2,
sigma-Aidrich) and ryanodine receptor type-3 (RyRs 3: rabbit polyclonal anti-ryanodine
receptor type•-3, Millipore Bioscience Research Reagents, Temecula, USA) diluted in PBS
and followed by additional incubation with horseradish peroxidase-conjugated goat
anti-rabbit lgG (Southern Biotechnology Associates inc., Birmingham, AL, USA) diluted 1:
sOOO for 2 h at room temperature. Finally, separated proteins were detected with
chemiluminescence (Pierce, Rockford, USA).
Protein measurement
   Protein concentration in sampies was assayed by the method of Lowry et al. 37) using
bovine serum albumin as standard.
Statistical analysis
  All data are presented as the mean Å} SEM. The statisticai significance of differences
between groups was assessed by the methods described in each figure legend after the
application of one-way ANOVA.
Drugs
  METH was obtained from Dainihon Pharmaceutical Co., (Tokyo, Japan). Nifedipine,
dantrolene, SCH23390 and sulpiride were purchased from Sigma-Aldrich (St. Louis, USA).
  METH and SCH23390 were dissolved in saline. Nifedipine, dantrolene and sulpiride
were dissolved in 10 O/o dimethyl sulfoxide in saline.
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Results
Blockade of the development of METH-induced place preference by RyRs antagonist
   ln order to examine the role of RyRs in the development of METH-induced place
preference, 1 investigated the effect of dantrolene, an antagonist ofRyRs, on
METH-induced place preference using conditioned place preference paradigm. METH (1
mg/kg, s.c.) produced significant place preference for the drug-associated place (Fig. 1),
which was suppressed by intracerebroventricularly pretreated dantrolene in a
dose-dependent manner, while dantrolene alone showed no effects on place preference
(Fig. 1). To further investigate how RyRs were modified in the brains of
METH-conditioned mice, 1 measured RyRs expression by Western blot analysis. Western
blot analysis showed significant increases of RyR-1 and -2 in the frontal cortex and
significant increase of RyRs 1 in the limbic forebrain in mice with METH-induced place
preference (Fig. 2), whereas RyRs 3 in the frontal cortex and RyR-2 and -3 in the limbic
forebrain in METH-conditioned mice were unchanged (Fig. 2).
   Asingle dose (1 mg/kg) of METH produced no effects on the expression of all types of
RyRs in the frontal cortex, limbic forebrain and cerebellum not only 24 hr but also 6 days
after its administration (Fig. 3).
Effect of nifedipine on increase in expression of RyRs 1 and 2 proteins in the brain of
METH-conditioned mice
   Chronic administration of METH produced significant place preference in mice, which
was dose-dependently inhibited by nifedipine (10, 30 nmoVmouse, i.c.v., Fig. 4). Under
these conditions, both Ca.1.2 and Ca.1.3 significantly increased in the frontal cortex and
the limbic forebrain of mice showing the rewarding effect (Fig.5). It is possible that the
increased expression of RyRs induced by METH may be regulated by L-type VGCCs.
Therefore, as the next step, 1 examined whether nifedipine produced any effects on the
up-regulation of RyR-1, and •-2 in the frontal cortex and of RyR-1 in the limbic forebrain
induced by METH. As shown in Fig. 6, increased expression of RyRs was not affected by
i.c.v. pretreatment with nifedipine at the dose that blocked the METH-induced place
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preference.
Effect of dantrolene on increase in Cavl.2 and Ca.1.3 proteins in the brain of
METH-conditioned mice
   1 further investigated whether the blockade of RyRs produced any changes in Ca.1.2
and Ca.1.3 protein expression in the frontal cortex and limbic forebrain obtained from
METH-conditioned mice. Ca,1.2 and Ca.1.3 proteins significantly increased in the brains
of mice with METH-induced place preference as shown in Fig. 7. Under these conditions,
the increase in the levels of Ca.1.2 and Ca.1.3 proteins in the frontal cortex and limbic
forebrain was not changed by i.c.v. pretreatment with dantrolene at the dose that blocked
the METH-induced place preference (Fig. 7).
Blockade of the development of METH-induced place preference by dopamine
receptor antagonists
   As dopaminergic receptors functionally related to mesolimbic dopaminergic neurons
have been well established to participate in the development of METH-induced place
preference, the effect of dopaminergic receptor blockade on METH-induced place
preference was examined. The METH-induced place preference was suppressed by i.c.v.
pretreatment with a DIDR antagonist SCH23390 (Fig. 8A) and a D2DR antagonist
sulpiride (Fig. 8B) in a dose-dependent manner, while SCH23390 and sulpiride alone
showed no effects on place preference (Fig. 8A, B).
Effect of SCH23390 and sulpiride on increase of RyR-1 and -2 proteins in the brain of
METH-conditioned mice
   Based on the inhibitory activity of the blockade of dopaminergic receptors on
METH-induced place preference, 1 further investigated of which dopamine Dl and D2
receptors had a regulatory potential on RyRs expression. Effect of SCH23390 on the
increase in RyR-1 and -2 proteins in the frontal cortex and RyR-1 in the limbic forebrain of
METH-conditioned mice was examined. Increased expression of RyRs by METH was
completely aboiished by i.c.v. injection of SCH23390 at the dose that significantly
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suppressed the METH-induced place preference (Fig. 9). Similarly, effect of sulpiride on
the increase in RyR-1 and -2 proteins in the frontal cortex and RyR-1 in the limbic forebrain
in METH-conditioned mice was examined, As shown in Fig. 10, METH-induced increase
of RyR expression was not affected by i.c.v. administration of sulpiride at the dose that
significantly suppressed the METH-induced place preference.
14
     21]O
    I., iBe
    ;, lt',e
    :. t40
    .;. 12g
    ."..'iiee
    S. ge
    1/ tiG
    g, 4o
    e
    a 20
      b[},m""Iei}e
ftsc"
io l 3 lO
litfnol n}"u$e, i.c.v.b
SAI. tv}El'H tlttig k{J. s:4i)•}
Figure 1. Effect of dantrolene on the METH-induced place preference in mice. Mice were
pretreated with vehicle or dantrolene (1, 3 or 10 nmol/mouse, i.c.v.) before subcutaneous
administration of saline (SAL) or METH. Groups of mice were subcutaneously treated with
SAL or METH every other day for 6 days (during the conditioning session: 3 days for METH,
3 days for saline). Each column represents the mean Å} S.E.M of 10 mice. "-pÅqO.OOI vs
vehicle-saline group (Bonferroni's test), ##pÅqO.Ol, ###pÅqO.OOI vs vehicle-METH group
(Bonferroni's test).
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fronta[ cortex; LF, limbic forebrain; CE, cerebellum. Mice were subcutaneously
administered METH (1 mg/kg) and the brain tissues were dissected 24 hr and 6 day after
the METH administration. Each column represents the mean Å} S.E.M. of 4 mice.
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Figure 4. Effect of nifedipine on METH-induced place preference in mice. Mice were
pretreated with vehicle or nifedipine (3, 1O or 30 nmol/mouse, i.c.v.) before subcutaneous
(s.c.) administration of saline (SAL) or METH (lmg/kg). Groups of mice were
subcutaneously treated with saline or METH every other day for 6 days. Each column
represents the mean Å} S.E.M of 10 mice. "'pÅqO.OOI vs vehjcle-saline group
(Bonferroni's test), #pÅqO.05, ###pÅqO.OOI vs vehicle-METH group (Bonferroni's test).
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Figure 5. Changes in protein levels of Ca. 1.2 and Ca. 1.3 in membrane fractions of the
mouse frontal cortex and limbic forebrain following the METH•-conditioning. FC, frontal
cortex; LF, limbic forebrain. Groups of mice were s,c. treated with saline (SAL) or METH
every other day for 6 days. The membrane fractions used for measuring Cav 1 .2 and Cav
4.3 were prepared 24 hr after the last conditioning with METH or SAL. Each column
represents the mean Å} S.E.M. of 4 mice. "'pÅqO.OOI vs SAL (Bonferroni's test).
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Figure 6. Effect of nifedipine on increase in RyR-1 (A) and -2 (B) proteins in the frontal
cortex and in RyR-1 (C) protein in the limbic forebrain obtained from METH-conditioned
mice, FC, frontal cortex; LF, limbic forebrain. Groups of mice were subcutaneously
treated with saline (SAL) or METH every other day for 6 days. Intracerebroventricular
treatment with vehicle or nifedipine (30 nmollmouse) was carried out 30 min before METH
(1mg/kg, s.c.) or saline injection. The membrane fractions used for measuring RyRs were
prepared 24 hr afterthe last conditioning with METH or SAL. Each column represents the
mean Å} S.E,M. of 4 mice. 'pÅqO.05, 'depÅqO.Ol vs. SAL (Bonferroni test).
20
tAl C' ",1.2
[ijiptpag[!!N
C,y1,3 tBb Åíla,1,2
twt' ge'i'
• ptpa
  P-,ICtilb
   16e
   t40
   l20
   100
 E
  ! 80
  r.
 ?• 6e
    ;e
    zo
    oD,}nttolene
EEii!!E!E!il
  C,Nl.3
wt ?lekoa
E 4?kOn
10 io
t"M nioitse. i.c.v.)
         SAL METH
. io le lo - le . 10 . tO
SAL METH SAt METH SAL METH
F(1 LF
Figure 7. Effect of dantrolene on increase in Cavl.2 and Ca,1.3 protein expression in the
frontal cortex and limbic forebrain obtained from METH-conditioned mice. (A) FC, frontal
cortex; (B) LF, limbic forebrain. Groups of mice were treated s.c. with saline ÅqSAL) or
METH every other day for 6 days. 1.c.v. pretreatment with vehicle or dantrolene (10
nmol/mouse) was performed 30 min before METH (lmg/kg, s,c.) or SAL injection. The
membrane fractions used for measuring RyRs were prepared 24 hr after the Iast
conditioning with METH or SAL. Each column represents the mean Å} S.E.M, of 4 mice.
-k pÅqO.OOI vs. SAL (Bonferroni's test).
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Figure 8. Effects of SCH23390 and sulpiride on the METH-induced place preference in
mice. Each column represents the mean conditioning scores Å} S.E.M. of 10 mice. Mice
were treated with (A) SCH23390 (3, 10 and 30 nmollmouse, i.c.v.) and (B) sulpiride (3, 10
and 30 nmol/mouse, i.c,v,) before the administration of saline or METH (lmg/kg, s.c,).
SCH23390 and sulpiride were dissojved in saline. "'pÅqO.OOI vs. SAL-SAL group
(Bonferroni's test), #pÅqO.05 and ###pÅqO.OOI vs. SAL-METH group (Bonferroni's test).
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Figure 9. Effect of SCH23390 on increase in (A) RyRs 1 and ÅqB) RyRs 2 proteins in the
frontal cortex and in (C) RyRs 1 protein in the limbic forebrain obtained from
METH-conditioned mice. FC, frontal cortex; LF, Iimbic forebrain, Mice were
subcutaneously treated with saline (SAL) or METH every other day for 6 days.
Intracerebroventricular treatment with vehicle or SCH23390 (30 nmol/mouse) was carried
out 30 min before METH (1mg/kg, s.c.) or saline injection. The membrane fractions used
for measuring RyRs were prepared 24 hr after the jast conditioning with METH or SAL.
Each column represents the mean Å} S.E.M. of 4 mice. ""pÅqO.OOI vs. SAL (Bonferroni's
test). "##pÅqO.OOI and "##pÅqO.OOI vs. SAL-METH group (Bonferroni's test).
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Figure 10. Effect of sulpiride on increase in (A) RyR-1 and (B) RyR-2 proteins in the
frontal cortex and in (C) RyR-1 protein in the limbic forebrain obtained from
METH-conditioned mice. FC, frontal cortex; LF, limbic forebrain. Mice were
subcutaneously treated with saline (SAL) or METH every other day for 6 days.
Intracerebroventricular treatment with vehicle or sulpiride (30 nmoVmouse) was carried out
30 min before METH (1mglkg, s.c.) or saline injection. The membrane fractions used for
measuring RyRs were prepared 24 hr after the last conditioning with METH or SAL. Each
column represents the mean Å} S.E.M. of 4 mice. '"pÅqO.OOI vs. SAL (Bonferroni's test).
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                              Discussion
    1 demonstrated the role of RyRs and VGCCs in METH-induced place preference.
The place conditioning procedure has been used as it is a well established one to evaluate
the motivational properties and this procedure has been reported to be more frequently
used than the self-administration paradigm38).
    The present study using the place conditioning procedure as a behavioral assay
demonstrated that i.c.v. pretreatment with nifedipine produced a dose-dependent inhibition
of METH-induced rewarding effect, which is in good agreement with previous reports
showing the inhibition by diltiazem of place preference induced by METH and
cocaine27'39'40). It has been reported that the nucleus accumbens of the mesolimbic
dopamine pathway may be essential in regulating the rewarding effects of many stimuli
jncludjng drugs of abusei5) and that the frontal cortex js also considered to be responsible
for stimulus-reward learning4i). Taken together with these data it is reasonable to
conclude that L-type VGCCs play an important role to establish METH-induced place
preference and that up•-regulation of Cavt.2 and Cavl.3 in the frontal cortex and limbic
forebrain may be involved in the development of METH-induced place preference.
    1 found in the present study that i.c.v. administration of a specific RyR antagonist,
dantrolene, suppressed the place preference produced by METH. Moreover, this study
demonstrates that the levels of RyR-1 and •-2 in the frontal cortex and RyR-4 in the limbic
forebrain obtained from METH-conditioned mice significantly increased as compared with
those in saline-conditioned mice. On the other hand, METH-conditioning failed to affect
the levels of RyR-3 in the frontal cortex and both RyR-2 and -3 in the limbic forebrain. In
addition, there were no changes in RyRs in the cerebellum after METH-induced place
preference. As the previous report indicates that the cerebellum is a brain region that
does not have an established role in drug abuse 42}, the lack of change in cerebellar RyRs
is consistent. The results presented here therefore suggest that RyR-1 and -2 may play a
key role in the development of METH abuse.
  Among these isoforms, RyR-1 known as the skeletal muscle isoform does not require
influx of extracellular Ca2' for activation, while surface membrane depolarization sensed
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by L-type VGCCs is transduced to RyR-1, likely by direct protein-protein interaction.
RyR-1 is co-immunoprecipitated with L-type VGCCs (Cavl.2), providing possibility of
functional coupling between these two proteins43). Such functional interaction between
these proteins has been demonstrated in neurons33). Therefore, it is likely that both
L-type VGCCs and RyR-1 may participate in the development of METH-induced place
preference.
   Several studies have reported that dantrolene and nifedipine blocked KCI-evoked
increase in intracellular Ca2' concentration44} and the stimulating effect of KCI presumably
results from membrane depolarization with subsequent activation of L--type VGCCs and
further CICR from the ryanodine-sensitizing Ca2" store45'46). such functional potentiation
of intracellular Ca2' dynamics may lead to the working hypothesis that these increased
Ca2" dynamics also bi-directionally regulates expression of these two types of functional
proteins, L-type VGCCs and RyRs, in METH-induced place preference. In this study 1
therefore examined the effect of nifedipine on expression of RyR•-1 and -2 proteins in the
frontal cortex and RyR-1 proteins in the limbic forebrain obtained from METH-conditioned
mice. The results showing that the increase of RyR-1 and -2 proteins in the frontal cortex
and RyR-1 proteins in the Iimbic forebrain by METH-conditioning was not changed by i.c.v.
pretreatment with nifedipine at the dose biocking the METH-induced place preference,
suggest that increased Ca2' concentration has no potential to regulate RyR-1 even under
the conditions with METH treatment.
   It js well known that place preference produced by repeated METH administration was
associated with increased dopamine release from dopaminergic neurons located in the
mesoljmbjc system, whjch suggests that DRs jn the nucleus accumbens and ljmbjc
forebrain may be activated to stimulate expression of RyRs after repeated METH exposure.
As shown in the present study, the blockade of DIDRs and D2DRs by thejr respective
selective antagonists, SCH23390 and sulpiride, attenuated the place preference induced
by METH. These roles of both DlDRs and D2DRs in the development and expression of
place preference of METH shown in this study is in good agreement with those in previous
reports47'48). tn contrast to the inhibitory effects by the blockade of both types of
dopamine receptors on the METH-induced behavioral changes, SCH23390, but not
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sulpiride, significantly inhibited the increased expression of both RyR-1 and RyR-2 in the
frontal cortex and RyR-1 in the limbic forebrain evoked by METH. These results provide
direct evidence that the up-regulation of RyRs observed during METH treatment is
mediated through the activation of DlDRs, but not of D2DRs.
   Previous reports indicate that both DlDRs and D2DRs can mediate reinforcing signals
of abuse49), despite the opposing actions of these two types of DR on cellular signaling
jnvolved jn protejn kinase A (PKA). That is, DIDRs stimulate adenylate cyclase through
stimulatory Gcts protein, while D2DRs showed their effects through inhibitory God/o protein.
In addition, PKA signaling in the nucleus accumbens involves in expression of animal
behaviors50-52År. Therefore, the present study may give a possibility to explain, in part,
why both DIDRs and D2DRs coupling with opposite cAMP-related signaling have similar
participation in the development of METH-induced behavioral changes. DIDRs may
induced METH-induced place preference via changing function of RyRs possibly mediated
by pathway involving in cyclic AMP, whereas D2DRs may participate in the neurochemical
events in which RyRs do not participate. However, the mechanisms of different
regulatory effects of DlDRs and D2DRs on RyRs expression remain to be elucidated at
present.
   In the present study, we examined whether a single dose of METH, but not repeated
METH administration, affects the expression of RyRs. The single dose of METH did not
produce any changes in the expressjon of RyRs ejther 24 hr or 6 day after METH
administration. These date clearly indicate that repeated administration of METH, but not
acute administration, is essential to change the expression of RyRs.
   In conclusion, the present data demonstrate that the repeated in vivo treatment with
METH induces an increase in L-type VGCCs and RyRs expression in the mouse frontal
cortex and limbic forebrain. The METH-induced place preference was significantly
suppressed by nifedipine and dantrolene. The increase in RyR-1 and -2 proteins in the
frontal cortex and RyR-1 jn the limbjc forebrain of METH-conditioned mice was completed
suppressed by DIDR blockade. These results indicate that the METH-induced
up-reguiation of RyRs, which can lead to the expression of psychological dependence, is
regulated by DIDRs. Furthermore, the present findings provide further evidence that
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L-type VGCCs and RyRs play a critical role in the development of METH-induced place
preference observed as a sign in METH-induced psychological dependence, and the
blockade of functions of these proteins by their selective antagonists, nifedipine or
dantrolene, is possible therapeutic approach for the treatment and prevention of
METH-induced psychological dependence.
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Chapter 2
Dopamine Dl receptor signaling system regulates ryanodine receptor expression
after intermittent exposure to methamphetamine in primary cultures of midbrain and
cerebral cortical neurons
29
                               lntroduction
   As described in chapter 1, increased expression of RyRs in the mouse frontal cortex
and limbic forebrain, the brain regions participating in the development of psychological
dependence, occurs in mice showing METH-•induced place preference, which is
considered to be one of suggestive behavioral makers defined as the development of
psychostimulant-induced psychological dependence, and this METH-induced place
preference was significantly suppressed by dantrolene, a RyR antagonist. It is therefore
considered that RyRs may one of important players to be involved in the development of
METH-induced place preference.
  METH-induced elevation of extracellular dopamine concentration results in complex
neurochemical changes and profound psychiatric effects53'54). Dopamine signats are
mediated by two major subfamilies of DRs, termed as DIDRs and D2DRs, for producing
rewarding effects of drugs of abuse55'57). These results suggest that RyRs play a
significant role in METH-induced psychological dependence and that DRs may participate,
in part, in up-regulation of RyR expression in the brain of mice showing METH-induced
place preference.
   1 examined mechanisms to regulate RyR expression, especially how Dl DRs regulate it,
using mouse midbrain and cerebral cortical neurons in primary culture exposed
intermittently to METH and drugs directly acting on DRs.
30
Materials and methods
Primary culture of midbrain and cerebral cortical neurons
   Pregnant female ddY mice with gestation of 15 days (12 weeks old; Japan SLC, lnc.,
Hamamatsu, Japan) were used to obtain fetuses for isofiate of neurons after deep
anesthesia with sodium pentobarbital (50 mg/kg, i.p.).
   Isolation and primary culture of midbrain and cerebral cortical neurons were carried
out according to the method described previously58) with a minor modification. In brief,
the midbrain and neopallium free of meninges were dissected from 15-day-old fetuses of
ddY strain mice anesthetized, minced, treated with trypsin, and centrifuged. The pellet
obtajbed was suspended wjth Dulbecco's modified Eagle's medium (DMEM) supplemented
                                                                     6with 15 e/o bovine calf serum, and an aliquot of cell suspension (cell number 3 x 10
cells/ml) was innoculated in a poly-L-lysine-precoated culture dish and cultured in
humidified 95 O/o air-5 O/o C02 at 37 OC for 3 days. The cejis were further cujtured jn
DMEM containing 10 O/o horse serum under the same conditions described above after
exposing the cells to 10 pM cytosine arabinoside dissolved in DMEM with 10 O/o horse
serum for 24 hrs to inhibit the proliferation of non-neuronal cells. The neurons were used
for the following experiments on 13th day of the culture. More than 95 O/o of cultured cells
were identified as the neurons by immunohistochemical analysis58).
Immunofluorescence
   On the 13th day of culture (the cerebral cortical and midbrain neurons), tyrosine
hydroxylase (TH), Lny-aromatic amino acid decarboxyiase (AADC) and dopamine transporter
(DAT) in the neurons were identified by immunofluorescence using rabbit anti-DAT
antibody (1:1000 diluted), mouse anti-AADC (1:5000 diluted) and goat anti-TH (1:5000
diluted) antibody in phosphate buffer saline (pH 7.4: PBS) containing 1 Olo bovine serum
aibumin. They were incubated with the antibodies for TH, AADC and DAT overnight at 20
e C followed by the incubation with Cy3-conjugated donkey anti-goat antibody (4:200) for
anti-TH antibody, FITC-conjugated donkey anti-mouse antibody (1:200) for anti-AADC
antibody, and Cy5-conjugated donkey anti-rabbit antibody (1 :200) for anti-DAT antibody for
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2 hr at 20 eC. Negative controls consisted of the omission of primary antibody from the
incubation steps. Immunolabeling fluorescence was detected using a Leica TCS SP2
laser scanning microscope.
Stereology for counting of TH-positive neurons
   ln order to examine the number of cell body of TH+ neurons, the cerebral cortical and
midbrain neurons were plated on a ploy-L-lysine coated coverglass. After
immunostaining for TH and 4',6-diamino-2-phenylindole (DAPI), the coverglass was
mounted on glass slides using VectaMount AQ to estimate TH- neurons using a stereologic
microscope system. The neurons were quantified with Stereo lnvestigator software (MBF
Bioscience, Vermont, USA). A standardized contour to define the counting area was used
on all cultures and included approximately 80 O/o of the coverglass. The petrimetric probe
option was employed with a grid size of 50 x 50 pm and a counting frame of 300 x 300 pm.
An investigator blinded to the the cerebral cortical and midbrain quantified TH+ neurons
within each counting frame following standard inclusion criteria59År.
Quantification of dopamine in extraneuronal space
   For examining whether the stimulation of the neurons by high KCI (30 mM KCL)
corresponding to physiological electronic stimulation occurring in neurons can release
dopamine from the cerebral cortical neurons. We measured dopamine released from the
neurons after the exposure to high KCI and METH. The neurons were washed two times
with Hank's solution after discarding the culture medium and then incubated in
Krebs-Ringer bicarbonate buffer supplemented with 20 mM Hepes (KRB-Hepes: pH 7.4;
                                2+137 mM NaCl, 4.8 mM KCI, 2.7 mM Ca Cl2, 1.2 mM KH2P04, 1.2 mM MgS04.6H20, 25
mM NaHC03, 1O mM glucose) in the presence of 30 mM KCI or 1OpM METH at 37 OC for 1
hr. The medium was then subjected to dopamine measurement using high--performance
liquid chromatography with electrochemical detection (HTEC-500: Eicom Co.). Dopamine
was separated by a column with a mobile phase containing pH 3.5, O.1 M CH3COONa, 2.0
mM sodium 1-decane sulfonate, O.1 mM EDTA (2Na) and 170/o methanol at a flow rate of
230 ml/min, and identified according to its retention time. The amounts of dopamine were
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quantified by calculating peak areas. The baseline data were calculated as
concentrations in KRB-Hepes. The data that show the effects of KCI and
methamphetamine on dopamine release from the neurons to the medium (KRB-Hepes)
were expressed as a percentage of the corresponding baseline level.
Exposure of the neurons to agents
    ln this study, the neurons were intermittently exposed to METH. That is, the
neurons were exposed to METH jn DMEM supplemented wjth 10 O/o horse serum for 1 hr
and were then cultured for following 23 hr in the same medium without METH after two
times washings of the neurons with Hank's solution. This exposure schedule of the
neurons to METH was carried out for 3 days and then protein for analyzing RyRs
expression was extracted.
    SKF82958 (a fuil DIDR agonist) and quinpirole (a selective D2DR agonist) were
exposed to the neurons with the protocol similar to that of METH exposure. SCH23390 (a
DIDR antagonist), sulpiride (a D2DR antagonist), and KT570 (an inhibitor of protein
kinase A) were dissolved in Hank's solution and directly added in the culture medium 10
min before the addition of METH or DR agonists and then the neurons were exposed to
METH or agonists for 1hr. Such exposure schedule of the neurons to agents was carried
out for 3 days and then protein for analyzing RyRs expression was extracted.
Accordingly, the duration of exposure of the neurons to DR antagonists used here were 70
min every day.
    Even after the exposure to METH and agents acting on DRs, the actMty of the
neurons to exciude trypan blue did not change (data not shown), indicating that the
present experimental conditions to expose the neurons to these drugs induce no cellular
toxicity.
Western blotting
   The neurons were scraped off from culture dishes and homogenized in 10 volumes of
ice-cold buffer containing 10 mM Tris-HCI (pH 7.4), O.15 M NaCl, O.5 mM EDTA, 10 mM
NaF, O.5 O/o Triton X-1OO, and a protease inhibjtor cocktajl (Roche Djagnostics, lndianapolis,
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USA) using a Potter•-Elvehjem tissue grinder with a Teflon pestle. The homogenate thus
obtained was centrifuged at 1,OOO xg for 10 min at 4 OC. The resultant supernatant was
thereafter centrifuged at 100,OOO xg for 60 min at 4 OC to obtain the pellets that were
retained as the sample for Western blot analysis.
   The electrophoresis (applied protein: 20 pg/Iane for RyR-l and -3, 5 pg/lane for
RyR-2) was carried out using 3-80/o Tris-acetate gel (lnvitrogen, Carlsbad, USA) with size
of 8 Å~ 8 cm and thickness of 1.0 mm (150 V, 60 min). The proteins separated on the gel
were transferred to a nitrocellulose filter with a wet type transblotter (90 V, 60 min), and the
nitrocellulose filter was incubated over night at 4 OC with primary antibodies against RyR-1
(mouse monoclonal anti--ryanodine receptor type-1), RyR-2 (mouse monoclonal
anti-ryanodine receptor type-2), RyR-3 (rabbit polyclonal anti-•ryanodine receptor type-3),
CREB (rabbit polyclonal anti-CREB), and phospho (serl33)-CREB (mouse monoclonal
anti-phospho (ser133)-CREB: pCREB) diluted in phosphate-buffered saline (PBS)
containing 5 O/o nonfat dried milk and then further incubated for 2 h at room temperature
with horseradish peroxidase-conjugated goat anti-mouse lgG or horseradish
peroxidase-conjugated goat anti-rabbit lgG diluted t: 5000 in PBS containing 5 O/o nonfat
dried milk. Finally, separated proteins were detected with chemiluminescence (Thermo
Fisher Scientific; Rockford, USA).
  Monoclonal antibodies for RyR-1 and -2 obtained from Sigma-Aldrich show that each of
RyR-1 and -2 is identified as one band with the expected molecular weight of
approximately 550-560 kDa as reported previously 43). On the other hand, we analyzed
RyR-1 and -2 expression using polyclonal antibodies. As a results, these antibodies
detected several bands including one band with the expected molecular weight of RyR-1 or
-
2. In addition, polyclonal antibody for RyR-3 used here show only one band with the
expected molecular weight and other several bands with molecular weight smaller than
that of RyR-3 on Western blotting. Based on these experimental data, we concluded that
the polyclonal antibody for RyR-3 used here would be satisfactory to detect the expression
of RyR-3 (Fig. 14).
Real-time RT-PCR
34
   Using a Nonodrop spectrophotometer (Wilimington, USA), the amount of total RNA,
which was prepared from the neurons using TRIzol reagents (lnvitrogen Co., Tokyo,
Japan) according to the standard protocoi for RNA extraction, was quantified to measure
OD26o. Total RNA (200 ng) was reacted with Prime Script reverse transcriptase (Takara,
Kyoto, Japan). Quantitative PCR was performed with One SYBR@ PrimeScript @RT-PCR
kit Ii (Takara, Kyoto, Japan) using 7500 real-time PCR system (Applied Biosystems, Foster
city, U,S.A.) with the protocol supplied by the manufacturer. The data were analyzed by
7500 system SDS Software 1.3.1 (Appiied Biosystems) using the standard curve method.
The sequences of the primers for RyR-1 and RyR-2 were as followed: RyR-1 forward
primer, 5'- AAGTCCCACAACTTTAAGCG-3' and reverse primer:
5'-TCTTCTTGGTGCGTTCCTG-3' (NM-O09109.2). RyR-2 forward primer: 5'-
AGCTTGAAAGACACCGAGGA-3' and reverse primer: 5'-TAGAGAGCCATCTGCCACCT-3'
(NM-023868.2).
Materials
   METH was obtained from Dainippon Pharmaceutical Co., (Tokyo, Japan). SCH23390,
sulpiride, SKF82958, quinpirole, KT570, and actinomycin D were the products of
Sigma-Aldrich (St. Louis, USA). Antibodies against RyR-1 (mouse monoclonal
anti-ryanodine receptor typeny-1), RyR-2 (mouse monoclonal anti-ryanodine receptor type•-2),
and phospho (serl33)-CREB (mouse monoclonal anti-phospho (serl33)-CREB) were also
purchased from Sigma-Aldrich (St. Louis, USA). Antibodies against RyR-3 (rabbit
polyclonal anti-ryanodine receptor type-3) and CREB (rabbit polyclonal anti-CREB) were
obtained from Millipore Bioscience Research Reagents (Temecu(a, USA). Horseradish
peroxidase-conjugated goat anti-rabbit lgG and horseradish peroxidase-conjugated goat
anti-mouse igG were the products of Southern Biotechnology Associates lnc.,
(Birmingham, USA). Antibodies against DAT (rabbit polyclonal) and AADC (mouse
monoclonal) were purchased from Sigma-Aldrich (St.Louis, USA). Antibody against TH
(goat polyclonal) was obtained from Santa cruz biotechnology, lnc., (California, USA).
FITC-conjugated donkey anti-mouse antibody, Cy3-conjugated donkey anti-goat antibody
and Cy5-conjugated donkey anti-rabbit were the products of Jackson immunoresearch
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laboratories lnc., (Philadelphia, USA). Other agents used here were locally available and
of analytical grade.
Protein measurement
   Protein measurement was conducted as previsouly descrjbed in Chapter 1.
Statistical analysis
  Each of data is presented as the mean Å} SEM. Statistical analysis was performed
using Prism 5 (GraphPad, lnc., San Diego, USA). Independent group t test were used for
comparisons between two experimental groups. For multiple groups, the statistical
significance of differences was assessed by the methods described in each figure legend
after the application of one-way ANOVA followed by Bonferroni multiple comparisons test
with the significance level set at pÅqO.05 or Dunnett's post hoc test where appropriate.
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                                RESULTS
Characteristics of mouse midbrain and cerebral cortical neurons
   ln the present study, 1 checked the neurochemical characteristics of the midbrain and
cerebral cortical neurons, such as the presence of DAT and the capacity of the neurons to
release dopamine, because METH shows its pharmacological activity to increase
extraneuronal dopamjne concentration vja the enhancement of dopamine reiease from the
neurons as well as the inhibition of DAT60'6i). Representative images of immunoreactivity
of TH, AADC and DAT in the midbrain and cerebral cortical neurons are shown in Figs. 1
and 2. The lmmunoreactivites for DAT were observed in both the midbrain and cerebral
cortical neurons (Fig. 1 and 2). Triple-abeiing experiment showed that DAT was
co-localized with TH and AADC, the latter is considered to be a neurochemical maker to
dopaminergic neurons, in the midbrain and cerebral cortical neurons (Fig. 1 and 2). DAT
immunoreactMty was detected in the cell surface of both TH- and AADC-positive cells. In
addition, the number of TH+ neurons was about 1.59 O/o and O.54 O/o in the midbrain and
cerebral cortical neurons, respectively (Fig. 3). These resuits clearly demonstrate that
dopaminergic neurons are present in cell population of both the midbrain and cerebral
cortical neurons. We further analyzed that DA concentration in KRB in which the cerebral
cortical neurons were cultivated after the exposure to high KCI (30 mM) and METH (1O pM).
The exposure of the cerebral cortjcal neurons to KCI and METH in KRB for 1 h,
significantly increased DA concentration in KRB (Fig. 4). These neuropharmacological
and immunohistochemical studies show that the cerebral cortical neurons is considered to
be able to use for the experiments to examine the neurochemical changes due to
dopamine released in response to METH.
Methamphetamine increased RyRs expression in mouse midbrain and cerebral
cortical neurons
  To study whether there was the difference in RyR expression after intermittent METH
exposure in the presence or absence of DR antagonists in the midbrain and cerebral
cortical neurons of mice, l first determined how METH affected RyR protein levels in these
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two types of neurons. In the midbrain neurons, the intermittent exposure to METH (10
pM) increased the expression of RyR-1 and -2 proteins in a dose-dependent manner,
whereas such manipulation showed no effects on RyR-3 expression (Fig. 5A). In the
cerebral cortical neurons the intermittent exposure to METH (10 pM) increased the
expression of RyR-1 and -2 proteins in a dose-dependent manner, but not the expression
of RyRd-3 (Fig. 5B).
   I also measured the time course of RyR-1 and -2 expression after single exposure to
METH in the cerebral cortical neurons to examine whether METH after such short-term
exposure had potential to modify RyR expression. The proteins were extracted O, 3, 6
and 12 hr after the exposure of the neurons to METH for1 hr. As shown in Fig. 6, the
single exposure to METH for 1hr did not change the levels of RyR-1 and -2 proteins.
Effects of DR blockade on METH-induced increase of RyR expression in mouse
midbrain and cerebral cortical neurons
   1 therefore checked effects of DR blockade on METH-induced increase of RyR-1 and -2
expression using antagonists selective to DIDRs or D2DRs, SCH23390 and sulpiride,
respectively in the mouse midbrain and cerebral cortical neurons. As shown in Fig. 7,
SCH23390 significantly suppressed the METH-induced enhancement of both RyR-t and -2
proteins in a dose-dependent manner in the midbrain and cerebral cortical neurons. Fig.
8 shows that a D2DR antagonist, sulpiride, did not suppress the METH-induced
enhancement of both RyR-1 and -2 proteins. Using real-time PCR, l examined the level
of RyR-1 and -2 mRNA in the midbrain and cerebral cortical neurons intermittently exposed
to METH (10 pM). The intermittent exposure to METH significantly increased mRNA of
these receptor proteins in the midbrain neurons and cerebral cortical neurons (Fig.9).
These data indicate that the response of RyR and their mRNA expression to METH and the
behaviors of METH-induced enhancement of RyR expression by DR blockade are
considered to be almost same in both types of the neurons.
Effect of actinomycin D on METH-induced increase of RyR expression in cerebral
cortical neurons
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  Actinomycin D completely abolished the significant increase of RyR-1 and -2 proteins
produced by the intermittent exposure to METH in the cerebral cortical neurons (Fig. 1OA).
  Simiiarly, SCH23390 (10 pM) significantly suppressed the METH-induced
enhancement of RyR-1 and -2 mRNA in the cerebral cortical neurons (Fig. 1OB).
   Based on these data, it is reasonable to conclude that the METH-induced increased
expression of RyR-1 and -2 proteins is mediated via the increased synthesis of these
receptor proteins following increased synthesis of their mRNA after the activation of
DlDRs.
Effects of Dl and D2DR activation on RyR expression in cerebral cortical neurons
   1 further examined whether selective DIDR activation with SKF82958, a full DIDR
agonist, potentiated RyR-1 and -2 expression. Fig. 11A shows that the intermittent
exposure (1 hr exposure per a day, three times) to SKF82958 dose-dependently increases
the levels of RyR-1 and -2 proteins. SKF82958 (10 pM)-stimulated increase of RyR-1 and
-
2 proteins were significantly blocked by 10 pM SCH23390 (Fig. 11B). SKF82958 (1O yM)
also shows significant stimulatory effect on RyR-1 and -2 mRNA expression and this
enhancement was also completely abolished by the concomitant exposure to SKF82958
and SCH23390 (10 pM) (Fig. "C). These results clearly indicate that DIDRs have
potential to regulate RyR-4 and -2 expre$sion via increased transcription of their genes.
   On the other hand, a D2DR agonist, quinpirole, showed no effects on the expression of
both RyR-1 and -2 proteins (Fig. 11D). Taken together with these data, it is concluded
that D2DRs do not participate in the regulation of RyR-1 and -2 expression.
Involvement of protein kinase A in METH-induced increase of RyR-1 and -2
expression in cerebral cortical neurons
   DIDRs coupling with Gcts-protein activate adenylate cyclase to increase cAMP
formation and subsequent activation of PKA, which suggests that DlDRs may participate
in the METH-induced up-regulation of RyRs via PKA activation. 1 therefore attempted to
examine how PKA played a role in the increase of synthesis of RyR 1 and 2 proteins
jnduced by DIDRs stjmulatjon. Fig. 12 demonstrates that a PKA inhibitor, KT5720,
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attenuates the METH-induced increase of both RyR-1 and •-2 proteins in a dose-dependent
manner. Thus, PKA activation is required in the up-regulation of RyR-1 and -2 protein
expression produced by DlDRs stimulation.
Effect of DlDR blockade on METH-induced CREB activation
  lt is well known that the transcription factor CREB is abundantly expressed in the
nucleus of neurons, is activated through phosphorylation at serine 133 by cAMP and Ca2'
signals, and is involved in transferring transcription signals mediated by PKA to the
nucleus 62). Furthermore, stimulation of DIDRs by dopamine has been well documented
to induce a rapid and transient increase in CREB phosphorylation 63). In this study,
therefore, we attempted to examine the role of active CREB in synthesizing RyR-1 and -2
proteins by METH exposure. As shown in Fig.13, the short-term exposure of the cerebral
cortical neurons to METH (10 pM for 1 hr) elevated pCREB, but not CREB, and
enhancement of pCREB level by transient exposure to METH was completely abolished by
SCH23390, a selective DlDR antagonist.
40
JFigure 1. Immunohistochemical characteristics of mouse midbrain neurons. (A)
Immunostaining of anti-tyrosine hydroxylase (TH) immunoreactivity was shown as red. (B)
lmmunostaining of anti- L-amino- aromatic acid decarboxylase (AADC) immunoreactivity
was shown as green. (C) lmmunostaining of anti-dopamine transporter (DAT)
immunoreactivity was shown as bleu. (D) Feature of merged (A), (B) and (C). In several
neurons, TH, AADC and DAT are recognized to be co-localized. (E)-(G) Omission of
primary antjbody yielded the negative control. (E)Cy3, (F)FiTC and (G)Cy5. Scale bar:
100 ptm.
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Figure 2. Immunohistochemical characteristics of mouse cerebral cortical neurons. (A)
lmmunostaining of antFTH immunoreactivity was shown as red. (B) lmmunostaining of
anti-AADC immunoreactivity was shown as green. (C) lmmunostaining of anti-DAT
immunoreactivity was shown as blue. (D) Feature of merged (A), (B) and (C). In several
neurons, TH, AADC and DAT are recognized to be co-localized. (E)-(G) Omission of
primary antibody yielded the negative control. (E)Cy3, (F)FITC and (G)Cy5. Scale bar:
100 pm.
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Figure 3. Estimated number of TH-positive neurons in the mouse midbrain and cerebral
cortical neurons. After immunostaining for TH and DAPI, the coverslips were mounted on
glass siides. This allowed for the use of a stereologic microscope system for estimating
TH+ neuron numbers. The counting frame (300 pm x 300 pm) used to count neurons in
cover-slip mounted cultures from experiment 6 using the Stereo lnvestigator software.
43
ptv.'".-.
gs-
ggge
".e
gtt•
cr
14gg
l2ee
igge
sea
6gg
4gg
2ge
 e
. 25 . Ie
KCI
{{vMÅr
METX
{pAil}
Figure 4. The potential of the cerebral cortical neurons to release dopamine in response to
high KCI (30 mM) and METH (10 pM) in KRB for 1 h. DA concentration in extracellular
space was measured with high-performance liquid chromatography with electrochemical
detection. The concentration of dopamine in control was 118 Å} 1O.8 pmol/ml of the buffer.
The data were obtained from 5 separate experiments, each of which was carried out in
duplicate. -P Åq O.Ol, '"*P Åq O.OOI vs. control (Student's t-test).
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Figure 5. Effect of intermittent exposure to METH on expression of RyR proteins in
midbrain neurons and cerebral cortical neurons. (A) The midbrain neurons and (B)
cerebral cortical neurons were exposed to METH (1, 3 and 1O pM) for 1 h with cultivation in
the culture medium without METH for following 23 h. Such protocol to exposure the
neurons to METH was carried out for 3 days and then proteins were extracted for
measuring RyR expression. The data were obtained from 4 separate experiments, each
of which was carried out in duplicate. "P Åq O.05, "'P Åq O.Ol, ke'P Åq O.OOI vs. control (post
hoc DunnetVs test).
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Figure 6. Time course of RyR-•1 and -2 expression after intermittent exposure to METH in
the cerebral cortical neurons. (A) METH (10 pM) was exposed to the neurons for1 hr.
The protein were extracted O, 3, 6 and 12 hr after exposed to METH (lhr) for measuring
RyR expression. The data were obtained from 4 separate experiments.
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Figure 7. Effect of SCH23390 on expression of RyR 1 and 2 proteins in (A) midbrain and
(B) cerebral cortical neurons after intermittent exposure to METH. The protocol of METH
(10 pMÅr exposure was described in the legend of Fig. 1. SCH23390 (O.1,1 and 10 pM)
was added into the culture medium 10 min before METH (10 pM) exposure. After the
exposure of the neurons to both SCH23390 and METH for 1 hr, the culture medium was
discarded and the neurons were cultured with the medium in the absence of SCH23390
and METH for following 23 hr. Such protocol of the exposure to SCH23390 and METH
was carried out for 3 days and thereafter the neurons were subjected to extract protein.
The data were obtained from 4 separate experiments, each of which was carried out in
duplicate. 'P Åq O.05,"P Åq O.Ol, 'keP Åq O.OOI vs. control (post hoc Bonferroni's test). "P Åq
O.05, ##P Åq O.Ol, "##P Åq O.OOI vs. METH-treated neurons Åqpost hoc Dunnett's test).
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Figure 8. Effect of sulpiride on expression of RyR 1 and 2 proteins in (A) midbrain and (B)
cerebrat cortical neurons after intermittent exposure to METH. The protocol of METH (10
pMÅr exposure was described in the legend of Fig. 1. Sulpiride (1O pM) was added into the
culture medium 10 min before METH exposure. After the exposure of the neurons to both
sulpiride and METH for 1 hr, the culture medium was discarded and the neurons were
cultured with the medium in the absence of sulpiride and METH for following 23 hr. Such
protocol of the exposure to sulpiride and METH was carried out for 3 days and thereafter
the neurons were subjected to extract protein. The data were obtained from 4 separate
experiments, each of which was carried out in duplicate. 'P Åq O.05, "P Åq O.Ol, "'P Åq
O.OOI vs. control (post hoc Bonferroni's test).
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Figure 9. Effect of intermittent exposure to METH on RyR mRNA in (A) midbrain and (B)
cerebral cortical neurons. The neurons were intermittently treated with to METH (10 pM)
as described in the legend of Fig. 1 for 3 days and were thereafter subjected to the
extraction of mRNA. The data were obtained from 4 separate experiments, each of which
was carried out in duplicate. *pÅqO.05, '*pÅqO.Ol, '*pÅqO.OOI vs. control (t-test).
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Figure 10. Effects of (A) actinomycin D (AD) and (B) DIDR blockade on expression of
RyR proteins in cerebral cortical neurons after intermittent exposure to METH. (A)
Pretreatment with actinomycin D (10"8 M) was performed 10 min before METH (10 pM)
exposure. After the exposure of the neurons to both AD and METH for 1 hr, the culture
medium was discarded and the neurons were cultured with the medium in the absence of
AD and METH for following 23 hn Such protocol of the exposure to AD and METH was
carried out for 3 days and thereafter the neurons were subjected to extract protein. (B)
Effect of SCH23390, a DIDR antagonist, on RyR mRNA after intermittent exposure to
METH. SCH23390 (1O pM) was added into the culture medium 10 min before the addition
of METH (10 pM). After the exposure of the neurons to both SCH23390 and METH for 1
hr, the culture medium was discarded and the neurons were cultured with the medium in
the absence of SCH23390 and METH for following 23 hr. Such protocol of the exposure
to SCH23390 and METH was carried out for 3 days and thereafter the neurons were
subjected to extract mRNA, The data were obtained from 4 separate experiments, each
of which was carried out in duplicate. "P Åq O.Ol, "'P Åq O.OOI vs. control, #P Åq O,05, ##P Åq
O.Ol, ###P Åq O.OOI vs. METH-treated neurons (post hoc Bonferroni's test).
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Figure 11
in cerebral
were exposed to SKF82958 (a DlDR agonist;
in the culture
exposure to
subjected to extract protein.
(BÅr SCH23390
SKF82958 (10 pM).
for 1 hr, the culture medium was discarded and the neurons were cultured with the medium
in the absence of SCH23390 and SKF82958 for following 23 hr. Such protocol of the
exposure to SCH23390 and SKF82958 was carried out for 3 days and thereafter the
neurons were subjected to extract protein. MP Åq O.Ol, '"P Åq O.OOI vs. control; ##P Åq O.Oi
vs, SKF38393-treated neurons (post hoc Bonferroni's test). (C) Effects of SKF82958 and
SCH23390 on expression of RyR-1 and •-2 mRNA in cerebral cortical neurons. SCH23390
(10 pM) was added into the culture medium 10 min before the addition of SKF82958 (10
pM). After the exposure of the neurons to both SCH23390 and SKF82958 for1 hr, the
culture medium was discarded and the neurons were cultured with the medium in the
absence of SCH23390 and SKF82958 for following 23 hr. Such protocol of the exposure
to SCH23390 and SKF82958 was carried out for 3 days and thereafter the neurons were
subjected to extract mRNA. "P Åq O.Ol, 't'P Åq O.OOI vs. control; ##P Åq O.Ol vs.
SKF82958-treated neurons (post hoc Bonferroni's test). (D) Effects of quinpirole on
expression of RyR 1 and 2 proteins in the cortical neurons. The protocol to expose of the
neurons to quinpirole (a D2DR agonist; 1, 3 and 10 pM) was similar to those to METH and
SKF82958. The data were obtained from 4 separate experiments, each of which was
carried out in duplicate.
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Figure 12. Effect of KT5720 on expression of RyR 1 and 2 protein in the cortical neurons
after intermittent exposure to METH. The protocol of METH exposure was described in
the legend of Fig. 1. KT5720 (O.1, 1 and 10 pM) was added into the culture medium 10
min before METH (10 pM) exposure. After the exposure of the neurons to both KT5720
and METH for 1 hr, the culture medium was discarded and the neurons were cultured wjth
the medium in the absence of KT5720 and METH for following 23 hn Such protocol of the
exposure to KT5720 and METH was carried out for 3 days and thereafter the neurons were
subjected to extract protein. The data were obtained from 4 separate experiments, each
of which was carried out in duplicate. 'P Åq O.05, tiP Åq O.Ol vs. control (post hoc
Bonferroni's test); #P Åq O.05, ##P Åq O.Ol vs. METH•-treated neurons (post hoc Dunnett's
test).
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Figure 13. Effect of SCH23390 on expression of CREB and phospho-CREB in cerebral
cortical neurons after single exposure to METH. SCH23390 (10 pM) was added into the
culture medium 10 min before METH (10 pM) exposure for 1 hr. The protein for
measuring CREB and phospho-CREB was extracted for measuring these proteins. The
data were obtained from 4 separate experiments, each of which was carried out in
duplicate. 'P Åq O.05 vs. control; #P Åq O.05 vs. METH-treated neurons (post hoc
Bonferroni's test).
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Figure 14. Identification of RyR-3 by immunoblotting.
was carried out in homogenates of the cerebral cortical
Western blot
neurons.
detection of RyR -3
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                               DISCUSSION
   1 demonstrated that intermittent administration of METH induced significant
enhancement of RyR-1 and -2 proteins in the cerebral cortex of mice as well as produced
possible psychological dependence with increased METH-induced place preference64).
This study was therefore carried out for the purpose of define mechanisms of increase in
RyRs-1 and -2 proteins by METH using the primary cultures of mouse midbrain and
cerebral cortical neurons.
  The present study used the intermittent exposure of METH to the neurons as a protocol
of METH exposure, because mice were usually administered METH or other
psychostimulants every two days (three to five times for 6 to 10 days) for conditioning
place preference. Therefore, the duration and the pattern of the cultured neurons to be
exposed to METH in vitro is supposed to resemble that of neurons in brain to be exposed
to METH with administration protocol of METH for conditioning piace preference test,
because the duration of neurons in brain to be exposed to METH is supposed for
approximately 1 h after each administration of METH when considering the data based on
pharmocokinetic profile of METH in rodents65). The protocol with intermittent exposure to
amphetamine, that is similar to that used here, was also employed in the previous
investigation66), in which they reported that intermittent exposure to amphetamine (lpM,
for 5 min/day, for 5 days) showed a neurotrophic effect in PC12 cells. Under the
intermittent METH exposure to the neurons, METH increased RyR-1 and -2 proteins with
no changes of RyR-3, which is considered to be similar to the previous data that
intermittent administration of METH up-regulated expression of RyR-1 and-2 proteins, but
not RyR-3, in association with the development of conditioned place preference 64).
Furthermore, it was noted that the single exposure to METH for 1 hr did not up-regulated
RyR-1 and -2 proteins when measured them up to 12 hrafterthe exposure. These results
indicate that the increase in RyR expression requires repeated stimulation by METH as
demonstrated in this study.
                                          '
   ln the present study, 1 checked whether dopaminergic neurons were contained in the
neurons in primary culture derived from the midbrain and cerebral cortex of mice and
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whether the cerebral cortical neurons had potential to release dopamine by its membrane
depolarization with stimulation by high KCI (30 mM) or METH, as METH exhibited its
pharmacological action by increasing dopamine concentration in extracellular space via
both stimulating dopamine release from neurons to extracellular space and suppressing
dopamine re--uptake by DAT inhibition. The data presented as supplementary data show
the presence of dopaminergic neurons in neurons in primary cultures prepared from the
iT)ouse cerebral cortex and the ability of these neurons to release dopamine in response to
30 mM KCI and METH. Dopamine content in KRB after the stimulation by METH was 118
pmollmL of KRB and, when evaluating as concentration, it is equivalent to about 120 nM.
This concentration in extracellular space is supposed to be lower than that in synaptic
space immediately after its release, because this concentration in extracellular space is
considered to reflect that after dilution of dopamine by its diffusion from synaptic space to
extracellular space. Therefore, it is likely that dopamine concentration could be higher in
synaptic space immediately after its release and could be sufficient to stimulate both Dl
and D2DRs. In addition, immunohistochemical studies showing the presence of the
neurons having positive immunoreactivities to TH, AADC, a well-known neurochemical
marker for dopaminergic neurons, and DAT, indicate that the neurons were considered to
be appropriate for the purpose of this study. Several reports suggested that TH and
AADC are markers for dopaminergic neurons67-69). DAT is also considered to be a
possible marker for dopaminergic neurons69). Therefore, the neurons with the expression
of TH, AADC and DAT are considered to be able to use as a dopaminergic neuron model.
   The present results show that the response of RyR expression to METH exposure in
the presence or absence of DlDRs and D2DRs antagonist in the neurons prepared from
the midbrain and cerebral cortex are almost similar. In the cerebral cortical neurons, the
presence of both TH and AAAD and the potential to release dopamine in response to
stimulation with high KCL and METH were found. In addition, the previous reports
demonstrate the localization of DIDRs and D2DRs in the neurons both positive and
negative to immunoreactivity of TH55'70-72}. It is considered to be reasonable that
intracellular signal transduction system after DR activation in the neurons from these two
brain regions is almost same. Taken together with these,lconsider that the use of the
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cerebral cortical neurons has no problems to investigate effects of modification of DRs
function on RyR expression in the following experiment. Moreover, immunohistochemical
study shows the co-localization of immunoreactivity for three types of proteins, TH, AAAD,
and DAT, in both types of the neurons prepared from the midbrain and cerebral cortex of
mice, though the percentage of TH-positive neurons in the cultured of the cerebral cortex
is one-third of that of the midbrain.
   The intermittent METH exposure to the midbrain neurons and cerebral cortical neurons
increased RyR-1 and -2 proteins. DIDRs blockade with its selective antagonist
SCH23390 dose-dependently suppressed METH-induced the up-regulation of RyR-1 and
-
2 proteins. It is noteworthy that the same manipulation also completely inhibited the
increased expression of RyR--1 and -2 mRNA. On the other hand, sulpiride, a selective
antagonist for D2DRs, showed no effects on METH-induced increase in proteins of RyR-1
and -2. As demonstrated here the METH-induced increase of RyRs proteins was
accompanied with increase of their mRNA in the midbrain neurons and cerebral cortical
neuron$. Furthermore, the METH-induced increases of RyRs proteins were completely
abolished by actinomycin D in the cerebral cortical neurons, indicating that the
up-regulation of these receptor proteins is mediated via increased transcription of their
genes. These results also indicate that METH up-regu[ates RyR-1 and -2 proteins via
DlDR activation in association with increased induction of their gene transcription.
   1 further investigated regulatory role of DlDRs and D2DRs in RyR expre$sion by direct
exposure of the cerebral cortical neurons to their selective agonists. As shown in this
study, a selective DIDR agonist SKF82958 enhanced RyR-1 and -2 proteins, which is
considered to mimic the stimulatory effect of METH on RyR-1 and -2 protein expression,
whereas a D2DR agonist, quinpirole, did not show any effects on RyR expression.
   This study investigated the changes of expression of RyR$ by DlDR activation with a
full Dl DR agonist73'74), SKF82958, and a partial Dl DRs agonist, SKF38393. Although the
data obtained by using SKF38393 are not shown here, the pattern of responses of RyR-1
and -2 expression to these agonists were similar, but the minimal dose of SKF82958 to
stimulate the expression was about one-third of that of SKF38393.
   As Dl and D2DRs are coupled with Gs and Gi/o proteins, respectively, and thus they
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have opposite effects on intracellular signaling via cAMP/PKA pathway75), we examined
the involvement of PKA and of CREB in RyR expression. Our data demonstrate the
inhibitory effect of a PKA inhibitor, KT5720, on the METH-induced increase of RyR
expression and the abolishment of METH-induced enhancement of phospho-CREB by
SCH23390, a selective DlDRs antagonist. The latter event is consequent to decreased
cAMP production by DlDRs blockade, because PKA, one of cytosolic second messengers
including Ca2' and calmodulin kinases, phosphorylates CREB to facilitate target gene
transcription in heterogeneous systems and cultured neurons76'77). previous
investigations revealed that DIDRs activated immediate early gene expression and
locomotion in dopamine-depleted rats78'79). Moreover, the role of DIDRs in the
neurochemical and behavioral. adaptation induced by amphetamine80'8i) were reported.
Repeated amphetamine administration has also been reported to stimulate
DIDR-mediated signal transduction pathways including activation of several protein
kinases32'80'82), to enhance neuroadaptation in association with alterations in
phosphorylation of transcription factors such as CREB83), and to change expression of
neurotrophins including fibroblast growth factors84) and brain-derived neurotrophic factor
85). Based on the experimental results demonstrated here and the previously reported
data described above, it is reasonable to conclude that METH-induced up•-regulation of
RyR proteins is mediated by increased transcription of their genes via stimulated
DlDRs-related signal transduction system.
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Chapter 3
lnvolvement of NMDA receptors in ryanodine receptor expression in dopaminergic
neurons in the ventral tegmental area of mice with intermittent methamphetamine
treatment
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                              lntroduction
   Dopaminergic neurons located in the VTA and substantia nigra are involved in
processing and learning of reward related informationi5'86'87). Bursts of these
dopaminergic neurons producing dopamine release in their projection areas meditate
learning of cue reward associations and also provide an incentive motivational signal for
goal directed behavior88). Recent evidence indicates that synaptic plasticity at
glutamatergic inputs onto dopaminergic neurons plays important roles in reward-based
conditioning and development of drug addiction89) and that glutamatergic inputs activating
NMDA receptors appear to modify functions of dopaminergic neurons90). Therefore, such
regulation of plasticity in dopaminergic neurons by activation of NMDA receptors might
contribute to reward effect of drugs of abuse.
  NMDA receptor, classified as tetrameric or heteromeric ligand-gated ion channels
interacting with multiple intracellular proteins, are complexes consisting of NRI and NR2
subunits9iÅr. The differential expression of NR2 subunits in various regions of the brain
may account for the diversity of NMDA receptor subtypes92). In addition to the
involvement of NMDA receptors in the development of rewarding effect related to
psychological dependence by chronic administration of morphine93), several investigations
demonstrated that a NMDA receptor antagonist, MK-801 , with similar degree of the affinity
for NR2A and NR2B subunitd-containing NMDA receptors, suppresses morphine-, cocaine-
and METH-induced rewarding effect94-96). In addition, ifenprodil, a selective NR2B
subunit-containing NMDA receptor antagonist, dramatically blocks the development of
morphine- and METH-induced rewarding effect2i•97).
   Although several studies have demonstrated modified expression of RyRs under
neuronal pathophysiological conditions such as cerebral ischemia and in animal model of
Alzheimer's disease98'iOO), there are few available data on regulatory mechanisms of RyR
expression in the central nervous system under physiological and pathophysiological
conditionsiOi]i02). On the other hand, the intracellular increase in calcium concentration
via RyRs in the prefrontal cortex and limbic forebrain including the nucleus accumbens64}
as we" as L-type VGCCs30'3i) has been reported to be implicated in
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psychostimulant-induced behavioral and neurochemical changes. These data suppose
that there may be correlation between RyRs and NMDA receptors in dopaminergic neurons
present in VTA of mice showing METH-induced place preference.
   In the present study, therefore, 1 investigated the roles of NMDA receptors in RyR
expression in the VTA of mice showing place preference by METH.
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                         Materials and Methods
Animats
  The present study used male ddY mice (8 week old; Japan SLC, lnc., Hamamatsu,
Japan), which were housed in a room maintained at 22 Å} 1 eC and 55 Å} O.5 O/o in humidity
with 12 h lightidark cycle for one week (light on 8:OO A.M. to 8:OO P.M.) before the
experimental use. Food and water were available ad libitum.
Place Conditioning
   Place conditioning was conducted as previsouly described in Chapter 1.
   Animals in saline group were subcutaneously (s.c.) injected saline alone for 6
consecutive days, whereas mice in METH group were administered METH every two days
with saline injection on the days when METH was not administered. MK-801 and
ifenprodil were injected only before METH-conditioning sessions, but not before saline
injection.
  Vehicle, MK-801 (non-selective NMDA receptor antagonist; f, 3, 10 nmollmouse) or
ifenprodil (selective NR2B subunit-containing NMDA receptor antagonist; 3, 10, 30
nmol/mouse) was i.c.v. administered 30 min before s.c. treatment with METH (1 mg/kg, s.c.)
or saline (in the case of control of which mice were injected saline instead of METH).
Immunohistochemistry using brain slices
   Mice deeply anesthetized with sodium pentobarbital (50 mg/kg, i.p.) were perfused
through the left ventricle of the heart briefly with ice-cold phosphate buffer saline (PBS, pH
7.4; 22mMNaH2P04, 81mMNa2HP04, f50mMNaCl) followed by 4 O/o paraformaldehyde in
O.1 M phosphate buffer. The brains were then quickly removed and kept in the same
fixative as described above at 4 eC for 2 hours, cut into serial section of the anterior
midbrain with 50 pm in thickness that included the VTA with a microslicer (Lica
microsystems, Tokyo, Japan) for subsequent free-floating immunohistochemical
processing. The sections were rinsed with PBS and incubated for 1 hr in PBS (pH 7.4)
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with 1 O/o bovine serum albumin, O.05 O/o sodium azide, and O.3 O/o Triton X-100. Each
primary antibody for RyR•-1, RyR-2 , tyrosine hydroxylase (TH) and NR2B subunit diluted in
PBS containing O.05 O/o sodium azide and O. 3 O/o Triton X-100 (RyR-1, 1:5000; RyR-2,
l:5000; TH, 1:1OOOO; NR2B, 1:1OOO) was incubated with the brain slices for 48 hr at 20 OC.
The primary antibodies were rinsed and further incubated with each secondary antibody
for 2 h at 20 OC. Fluorescent immunoiabeling was carried out using Cy3-conjugated
donkey anti-mouse antibody for TH and NR2B subunit and FITC-conjugated donkey
anti-rabbit antibody for anti-RyR-t, RyR-2 and TH diluted 1:200 in PBS containing O.05 O/o
sodium azide and O.3 O/o Triton X-100 in PBS (pH 7.4). After rinsing in PBS the sections
were mounted in Vectashield (Vecter H-1000, VECTOR LABORATORIES lnc., CA, USA)
and was detected using a Leica TCS SP2 laser scanning microscope.
Western blotting
  lmmediately after the post-conditioning test, mice were decapitated, and the lower
midbrain including VTA (the anterior and posterior VTA) was quickly dissected on an
ice-cold metal place. The dissected brain tissues were homogenized in ice-cold lysis
buffer containing 10 mM Tris-HCI (pH 7.5), 150 mM NaCl, O.5mM EDTA, 10 mM NaF, and
O.5 O/o Triton X-1OO with a protease-inhibitor cocktail and centrifuged at 1,OOO xg for 1O min.
The resultant supernatant was centrifuged at 1OO,OOO xg for 60 min at 4 eC.
  Protein samples (5 pg protein applied onto each lane) thus obtained were separated by
3-801o Tris-acetate gel (lnvitrogen, Carlsbad, USA; 140V, lhr) and then transferred to
nitrocellulose membranes in Tris-glycine buffer (90 V, 1hr). For immunoblot detection, the
membrane was incubated overnight at 4 "C with primary antibodies against NRI (rabbit
polyclonal anti-NRI, 1:1000), NR2A (rabbit polyclonal anti•-NR2A, 1:1000), NR2B (rabbit
polyclonal anti- NR2A, 1:tOOO), ryanodine receptor type-1 (RyR-1: mouset monoclonal
anti•-ryanodine receptor type-1), ryanodine receptor type-2 (RyR-2: mouse monoclonal
anti•-ryanodine receptor type-2) and ryanodine receptor type-3 (RyR-3: rabbit polyclonal
anti-ryanodine receptor type-3) diluted in PBS and followed by additional incubation with
horseradish peroxidase-conjugated goat anti-rabbit lgG diluted 1: 5000 for 2 h at room
temperature. Finally, separated proteins were detected with chemiluminescence (Pierce,
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Rockford, USA).
   The selectivity of the antibodies to respective RyR isoforms is considered to be defined
by the reasons described below. That is, western blot analysis using the mouse lower
midbrain tissue shows the immunoreactivities of all three isoforms of RyRs. Each RyR
isotype was identified using isoform specific antibodies with bands of the expected
molecular weight of approximately 550-560 kDa i03). The immunogen of RyR-1,-2 and -3
are synthetic peptides of human ryanodine receptor 1 (NM.OO0540.2), human ryanodine
receptor 2 (NM..OOI035.2), and human ryanodine receptor 3 (NM-OOI036.3), respectively.
   Protein samples used for measuring RyRs and NMDA receptor subunits were
simultaneously prepared from the same mice in each group described above.
Protein measurement
   Protein measurement was conducted as previsouly described in Chapter 1.
Drugs
  Antibodies forryanodine receptor type-1 (RyR-1: rabbit polyclonal anti-RyR 1),
ryanodine receptor type-2 (RyR-2: rabbit polyclonal anti-RyR 2), ryanodine receptor type-3
(RyR-3: rabbit polyclonal anti-RyR 3), TH, and NR2B subunits of NMDA receptors were
obtained from Millipore Bioscience Research Reagents (Temecula, CA, USA). Antibodies
for NRI and NR2A subunits were purchased from Cell Signaling Technology, lnc. (Danvers,
USA). Horseradish peroxidase-conjugated goat anti-rabbit lgG and goat anti-mouse lgG
were purchased from Southern Biotechnology Associates lnc. (Birmingham, USA).
FITC-conjugated donkey anti-rabbit antibody and Cy3-conjugated donkey anti-mouse
antibody were purchased from Jackson lmmunoresearch lnc. (Pennsylvania, USA).
Protease-inhibitor cocktail and methamphetamine hydrochloride were products of Roche
Diagnostics (lndianapolis, USA) and Dainippon Pharmaceutical Co., (Tokyo, Japan),
respectively. MK-801 and ifenprodil were obtained from Sigma-Aldrich (St. Louis, USA).
METH was dissolved in saline. MK-801 and ifenprodil were dissolved in 10 O/o dimethyl
sulfoxide in saline. Other chemicals used here were locally available and of analytical
grade.
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Statistical analysis
  All data are presented as the mean Å} SEM. Statistical analysis was carried out using
Prism 5 (Graph Pad). The statistical significance of differences between groups was
assessed by the methods described in each figure legend after the application of one-way
ANOVA.
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                                 Results
lncrease in RyRs expression in the lower midbrain obtained from mice with
METH-induced place preference
   ln this study, 1 first examined the protein ievels of three RyR isoforms in the lower
midbrain of mice showing METH-induced place preference using Western blot anaiysis.
RyR-1 and -2 in the lower midbrain significantly increased after intermittent administration
of METH, whereas RyR-3 in the lower midbrain showed no changes (Fig. 1).
Blockade of development of METH-induced place preference by NMDA receptor
antagonists
  Among the enduring neuronal changes contributing to the expression of METH-induced
place preference, alterations in glutamatergic signaling and plasticity within VTA is
supposed to be an important event in the METH-induced place preference as described
above. In order to examine possible roles of NMDA receptors on the development of
place preference induced by METH, we investigated effects of MK-801 and ifenprodil on
the METH-induced place preference in mice using the conditioned place preference
paradigm. METH (1 mg/kg,s.c.) produced significant place preference in mice for the
drug-associated place. This METH-induced place preference was suppressed by
intracerebroventriculr (i.c.v.) pretreatment with a non-competitive NMDA receptor
antagonist, MK-801, (Fig. 2A) and a selective NR2B subunit-containing NMDA receptor
antagonist, ifenprodil, (Fig. 2B) in a dose-dependent mannen MK-801 and ifenprodil
alone did not induce either significant place preference or place aversion in mice (Fig. 2).
In addition, mice showed almost normal Iocomotor activity and no sedation after i.c.v.
injection of MK-801 and ifenprodil alone.
Changes of expression of NMDA receptor subunits in the lower midbrain obtained
from mice with METH-induced place preference
   As the significant abolishment of the METH-induced place preference by the b[ockade
of NMDA receptors with their antagonist supposed alteration of NMDA receptor function
                                   66
under these conditions, 1 further examined the levels of proteins of NMDA receptor
subunits in the lower midbrain using Western blot analysis. Fig. 3 shows significant
increase of NRI, NR2A and NR2B in the lower midbrain of mice showing METH-induced
place preference. The samples prepared from the mice of the same group used in the
experiment as demonstrated in Fig. 1 were used in the experiment shown in Fig.3.
Effect of ifenprodil on increased expression of RyR-t and -2 in the lower midbrain of
mice with METH-induced place preference
  Based on the inhibitory activity of the blockade of NR2B subunit-containing NMDA
receptors on the METH-induced place preference shown in Fig. 2B, we examined which
type of RyR isoforms was regulated by NR2B subunit--containing NMDA receptors. As
shown in Fig. 4, i.c.v. treatment with ifenprodil at the concentration showing significant
suppression of the METH-induced place preference significantly abolished the increased
expression of both isoforms of RyRs in the lower midbrain of mice.
Localization of immunoreactivity of RyR-1 and -2 in dopaminergic neurons in mouse
VTA
   ln order to examine whether RyR-1 and -2 were localized in dopamine neurons in the
VTA, double-labeling immunohistochemistry for both isoforms of RyRs and TH, the latter is
an rate-limiting enzyme of dopamine synthesis and used as a marker to define
dopaminergic neurons, was carried out using in the slices of the VTA prepared from mouse
brain. Co-localization of immunoreactMty of RyR-1 and TH was found in 80 cells of 92
TH-positive cells and 106 RyR-1 positive cells, respectively (Fig. 5A-C). Similarly,
co-localization of immunoreactivity of RyR•-2 and TH was found in 87 cells of 97
TH-positive cells and 115 RyR-2 positive cells (Fig. 5D-E). Thus, it is considered to be
reasonable to conclude that RyR-1 and -2 appear to be expressed in most of dopaminergic
neurons and also in small population of non-dopaminergic neurons in the VTA.
Locatization of immunoreactivity of NR2B subunits in dopaminergic neurons in
mouse VTA
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    As shown in Fig. 6, co-localization of immunoreactivity of NR2B and TH was found in
75 cells of 83 TH-positive cells and 97 NR2B subunit-positive cells in the VTA (Fig. 6).
Co-localization of immunoreactivity of RyRs and NR2B subunits in mouse VTA
    Similarly, we further examined whether RyRs were co-localized with NR2B subunits in
the mouse VTA. Fig. 7 shows that respective immunoreactivity of RyR-1 and -2 was
localized in 55 and 61 cells of 58 and 64 NR2B subunit-positive cells in the VTA,
respectively (Fig. 7). Thus, RyRs and NR2B subunits are considered to be expressed in
almost dopaminergic neurons in the VTA.
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Figure 1. Changes in RyR expression in the membrane fractions of the mouse lower
midbrain following intermittent METH administration. Mice were subcutaneously treated
with saline (SAL) or METH every other day for 6 days. The membrane fractions used for
measuring RyRs were prepared 24 h after the last dose of METH or saline. Each column
represents the mean Å} S.E.M. of four mice. '*'pÅqO.OOI vs. SAL (Bonferroni test).
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Figure 3. Changes in expression of NRI, NR2A and NR2B subunits in the membrane
fractions of the mouse lower midbrain following intermittent METH administration. Mice
were subcutaneously treated with saline (SAL) or METH every other day for 6 days. The
membrane fractions used for measuring NMDA receptor subunits were prepared 24 h after
the last dose of METH or SAL, and were simultaneously prepared on the preparation of
samples used in the experiment presented in Fig. 1. Each column represents the mean Å}
S.E.M. of four samples. ke'pÅqO.OOI vs. SAL (Bonferroni test).
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Figure 4. Effect of ifenprodil on increase in RyR-1 and -2 proteins in the membrane
fractions of the lower midbrains obtained from mice with METH-induced place preference.
Mice were subcutaneously treated with saline or METH every other day for 6 days.
Intracerebroventricular treatment wjth ifenprodil (30 nmol/mouse) was carried out 30 min
before METH (1 mglkg, s.c.) injection. The membrane fractions used for measuring RyRs
were prepared 24 h after the last dose of METH or saline. Each column represents the
mean Å} S.E.M. of four samples. xx"pÅqO.OOI vs. SAL (Bonferroni test). ###pÅqO.OOI vs.
vehicle-METH groups (Bonferroni test).
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Figure5. ImmunoreactivityofRyRsindopaminergicneuronsofthemouseVTA. (A)-(C)
lmmunostaining for (A) RyR-1 (green) and (B) TH (red) with (C) merged images for RyR-1
and TH (overlap appears yellow) Arrows indicate cells expressing RyR-1 but not TH.
(D)-(F) lmmunostaining for (D) RyR-2 (green) and (E) TH (red) with (F) merged images for
RyR-2 and TH (overlap appears yellow). Arrows showed the cells expressing RyR-2 but
not TH. Scale bar: 100 pm.
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Figure 6. Immunoreactivity of NR2B in dopaminergic neurons of the mouse VTA.
(A)-(C) lmmunostaining for (A) TH (green) and (B) NR2B (red) with (C) merged images for
TH and NR2B (overlap appears yellow). Arrows indicate cells expressing NR2B but not
TH. Scale bar: 100 pm.
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Figure 7. Immunoreactivity of NR2B subunits and RyRs in neurons of the mouse VTA.
(A)-(B) lmmunostaining for (A) RyR-1 (green) and (B) NR2B subunits (red) with (C) merged
images for RyR-1 and NR2B subunits (overlap appears yeljow). (D)-(F) lmmunostaining
for (D) RyR-2 (green) and (E) NR2B subunits (red) with (F) merged images for RyR-2 and
NR2B (overlap appears yellow). Scale bar: 100 pm.
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                               Discussion
   ln the present study, 1 provide first evidence that in the VTA, RyR-1 and -2 play an
important role in the process of the development of METH-induced place preference, and
NMDA receptors, especially by NR2B subunit-containing NMDA receptors are responsible
for expression of RyR-1 and -2.
  In Chapter 1, 1 described that intracerebroventricular administration of dantrolene,
significantly suppressed place preference produced by METH. Under these conditions,
RyR-1 in the nucleus accumbence and RyR-1 and -2 in the prefrontal cortex, to which
regions dopaminergic neurons project from the VTA, were found to increase and such
increased expression of RyRs was supposed to be mediated by the activation of DlDRs by
dopamine released from dopaminergic neuron$. In fact, the activation of mesoiimbic
dopaminergic neurons in the VTA is reported to be possibly involved in reward,
reinforcement, and emotiont04). It has been reported that the VTA is a functionally
heterogeneous brain region, with different sub-regions along the anterior-posterior axis
(the anterior and posterior VTA) mediating reinforcing effects of different agentsi05).
Furthermore, the posterior VTA are considered to be more highly responsible for
lever-press for administration of drugs such as nicotinei06), opiatesi07), cocainet08),
ethanoli09) than the anterior VTA. Taken together with these data, the changes of both
type of RyRs and NMDA receptors by METH and of METH-induced place preference may
be the neurochemical events occurring in the posterior VTA, though further examination is
necessary to define exact roles of the anterior and posterior VTA in regulating drug abuse.
   One of the interesting findings presented here is that significant increase of RyR-1 and
-
2 also occurs in the VTA of mice showing METH-induced place preference, though METH
failed to change the level of RyR-3 in the VTA. Based on the data of dose-responsive
inhibitory effects of MK-801 and ifenprodil on the METH--induced place preference in Fig. 2,
1 determined the doses of MK-801 and ifenprodil used in this study to examine effects of
these antagonists on METH-induced changes in RyR expression. In addition, there are
previous reports that place preference produced by chronic administration of METH is
suppressed by i.c.v. pretreatment with ifenprodil (10 nmoVmouse)2iÅr, and MK-8ol (6
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nmoVmouse, i.c.v.)iiO) until now. The doses of MK-801 and ifenprodil used in these
previous investigations are considered to be almost similar to those used here.
   Previous investigations have reported that the functions of the mesolimbic
dopaminergic neurons could be modulated by glutamate receptors in the VTA and nucleus
accumbensiii), and that MK-801, a NMDA receptor antagonist, suppresses morphine- and
cocaine-induced place preference95'96). 1 demonstrate in this study that i.c.v.
pretreatment with not only MK-801 but also a NR2B-specific NMDA receptor antagonist,
ifenprodil, significantly prevented the development of place preference induced by
intermittent administration of METH in mice. Furthermore, the present study
demonstrates that significant increase in NRI, NR2A, and NR2B subunits in the VTA by
intermittent administration of METH producing place preference in mice. Several studies
have also reported that direct microinjection of NMDA receptor antagonist into the VTA
attenuates the development of psychostimulant-induced behavioral sensitization i6•ii2).
Indeed, it is likely that increased activation of NMDA receptors in the VTA in association
with rewarding effects results, at least in part, from enhanced glutamatergic transmission
followed by depolarization of dopaminergic neuronsii3-ii5}.
  The data mentioned above give rise to two questions. The first one is whether there is
relationship between the up-regulation of RyRs and the increased expression of NMDA
receptors in the VTA of mice showing METH-induced place preference. As shown in this
study, under intermittent administration of METH the increase of RyRs in the VTA of mice
was significantly suppressed by a NR2B subunit-containing NMDA receptor antagonist,
which indicates that the expression of RyRs is positively modified by NMDA receptors.
The sustained increase in intracellular calcium induced by NMDA receptors could lead to
the prolonged activation of calcium--mediated second messengersii6'ii7). Intracetlular
calcium binds calmodulin to form an active complex that can regulate a lot of enzyme
functions including calcium/calmodulin-dependent protein kinase i and 11, all of which are
abundantly expressed throughout the central nerves systemii8). A common target of
calcium/calmodulin complex and mitogen-activated protein kinase kinases is CREB, a
transcription factor that has been linked to several forms of synaptic plasticity including
psychostimulant-induced changes in the mesotelencephalic dopamine systems83). Such
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increased expression of proteins of RyR-1 and -2 by METH is therefore considered to be
induced via such intracellular signal transduction pathway relating to activation of
calcium-mediated second messengers by NMDA receptors. In addition, the role of NMDA
receptors in neurochemical and behavioral adaptation induced by METH was also
reported2i). A recent investigation also reported nicotine-mediated RyR-2 up-regulation
by CREB in the VTAi"9), and NMDA-mediated and L-type calcium channel
activator-mediated increase of RyR-2i20). Furthermore, RyRs are modulated by nicotine
administration, and are linked to nicotine-induced neuronal plasticityii9'i2i). These data
therefore suggest that the changes in RyRs may be an important event to be linked to
neurochemical and behavioral adaptation in association with the alteration of neuronal
plasticity occurring in drug abuse. However, exact mechanisms of regulation of RyR
expression by NMDA receptors remain to be elucidated at present.
   The second question is whether the regulatory changes of RyRs by NMDA receptors
occur in the dopaminergic neurons in the VTA, jf NMDA receptors regulate RyR expression
as mentioned above. To determine this possibility this study examines the presence of
both types of receptors in dopaminergic neurons in the VTA using immunohistochemical
procedures. As shown here, the immunohistochemical examination demonstrates that
RyR-1 and -2 were expressed at the surface of TH-positive dopaminergic neurons.
Moreover, the co-localization of RyR-1 and -2 immunoreactivity was found in
NR2B-positive cells in the VTA. These immunohistochemical data clearly indicate that
most of both isoforms of RyRs and NMDA receptors co-[ocalize in dopaminergic neurons in
the VTA. The presence of localization of immunoreactMty for all type$ of RyRs in
neurons with TH immunoreactivity in the substantia nigra pars compacta has been
previously reportedi22). Therefore, based on these immunohistochemical data and the
results showing the relationship between RyRs and NMDA receptors, it is reasonable to
conclude that NMDA receptors including NR2B subunit-containing NMDA receptors may be
an important factor in the expression of RyR-1 and -2 in the VTA of mice with
METH-inducing place preference.
   In conclusion, the present study provides that repeated intermittent treatment of mice
with METH induces increased RyR-1 and -2 in the VTA. The increase expression of
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RyR-1 and -2 in the TH-positive dopaminergic neurons of VTA of mice showing
METH-induced place preference were suppressed by MK-801 and ifenprodil. These
findings indicate that NMDA receptors including NR2B subunit-containing NMDA receptors
is involved in regulatory expression of RyRs.
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Chapter 4
Dopamine Dl receptors participate in cocaine-induced
regulation of ryanodine receptor expression
place preference via
80
lntroduction
  Cocaine is a strong addictive psychostimulant that dramatically alters CNS function.
In addition to the pivotal role of Ca2' signaling via NMDA receptors, Ca2' influx via L-type
VGCCs is important for cocainet-induced behavioral and neurochemical changes30-32).
VGCCs are classified into distinct subtypes (L, N, PIQ, R, and T) based on their
pharmacological and biophysical properties22). L-type VGCCs (ctic and ctid subunits) are
heterometric complexes and show electrophysiological and pharmacological diversities23).
ctic and ctid subunits are dominant calcium channel-forming subunits of L-type VGCCs and
expressed in many types of neurons24).
   In the CNS, changes in intracellular Ca2' concentration play an regulatory role in
various CNS functions such as learning and memory25). Channels for jntracellular ca2'
release can be divided into two major categories: inositol-1, 4, 5-trisphosphate receptors
and RyRs, both of which are present on the endoplasmic reticulum, and release Ca2' into
intraceliular spaces from intracellular Ca2' pools in response to a variety of stimuli.
inositol-1, 4, 5-trisphosphate receptors and RyRs are activated by Ca2+ in the process of
CICR as well as by a change in membrane voltagei'35). In addition, functional interaction
between L-type VGCCs and RyRs in the CNS has also been suggested33'34). However,
little is known about the role of RyRs in psychological dependence on cocaine.
   In the present study, i examined whether RyRs were involved in the development of the
cocaine-induced place preference and how expression of RyRs was regulated under these
conditions.
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                         Materials and methods
Animals
  Maie ddY mice (8 weeks old; Japan SLC, lnc., Hamamatsu, Japan), which were housed
in a room maintained at 22 Å} 1 eC, and 55 Å} O.501o humidity with a 12 h light/dark cycle (light
on 8:OO A.M. to 8:OO P.M.) for 1 week prior to the experiments, were used. Food and
water were available ad Iibitum.
Place conditioning
   Place conditioning was conducted as described in Chapter 1.
Tissue dissection and preparation for western blot
   Tissue dissection and preparation for western blot was conducted as described in
Chapter 1.
Statisticat analysis
  All data are presented as the mean Å} SEM. Statistical analysis was carried using
Prism 5 (GraphPad, lnc., San Diego, USA). The statistical significance of differences was
assessed by the methods described in each figure legend after the application of one-way
ANOVA followed by Bonferroni multiple comparisons test or Dunnet post hoc test.
Drugs
  Cocaine hydrochloride was the products of Shionogi Co., (Osaka, Japan). The other
materials used were same as described in Chapter 1.
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Results
Blockade of development of cocaine-induced place preference by a RyR antagonist,
dantrolene
   l investigated the effect of dantrolene, a RyR antagonist, en the place preference by
cocaine. Mice conditioned with cocaine (10 mg/kg, s.c.) exhibited a significant
preference for the drug-associated place (Fig.1). Dantrolene (10 nmol/mouse, i.c.v.)
alone induced neither significant place preference nor place aversion in mice. Under
•these conditions, the significant place preference produced by cocaine was suppressed by
intracerebroventricular pretreatment with dantrolene in a dose-dependent manner (Fig. 1 ).
Changes in protein tevels of RyRs in the membrane fractions of the mouse frontal
cortex, limbic forebrain and cerebellum following cocaine-conditioning
   The Ievels of proteins of three RyR isoforms in the frontal cortex and limbic forebrain
obtained from cocaine-conditioned mice were also examined using Western biot analysis.
RyR-1 and -2 in the frontal cortex and limbic forebrain significantly increased by cocaine
conditioning, though there were no changes in the expressions of these two types of RyRs
in the cerebellum (Fig. 2). In contrast, the levels of RyR-3 in the frontal cortex and limbic
forebrain as well as the cerebellum obtained from the cocaine-conditioned mice showed no
changes (Fig. 2).
Effect of nifedipine on increase in RyR-1 and •2 expression in the frontal cortex and
limbic forebrain obtained from cocaine-conditioned mice
  1 examined how the bjockade of L-type VGCCs by njfedipine affected the increased
expression of these RyRs and there is functional interaction between L-type VGCCs and
RyRs known as CICR `3). Nifedipine pre-administered i.c.v. at the dose that significantly
blocked the cocaine-induced place preference did not produce any changes in the
increase of RyR-1 and -2 in the frontal cortex and iimbic forebrain (Fig. 3).
Effects of dantrolene on increase in ctic and (xid subunits of L-type VGCCs in the
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frontal cortex and limbic forebrain of cocaine-conditioned mice.
   I investigated effects of dantrolene on the increase in ctic and otid subunits of L-type
VGCCs protein expression in the frontal cortex and limbic forebrain of cocaine-conditioned
mice. Under these conditions, the i.c.v. pretreatment with dantrolene at the dose that
blocked the cocaine-induced place preference had no effects on the increase in cttc and
ctid subunits of L-type VGCCs proteins (Fig. 4).
Blockade of development of cocaine-induced place preference by dopamine
receptor antagonists
  The cocaine-induced place preference was suppressed by intracerebroventricular
pretreatment with a DIDRs antagonist, SCH23390 (Fig. 5A), and a D2DRs antagonist,
sulpiride (Fig. 5B), in a dose-dependent manner. Each administration of SCH23390 and
sulpiride alone changed no place preference or aversion (Fig. 5A and B). In addition,
mice showed almost normal locomotor activity and no sedation after i.c.v. injection of
SCH23390 and sulpiride alone.
Effect of SCH23390 and sulpiride on increased expression of RyR-1 and -2 in frontal
cortex and limbic forebrain of cocaine"conditioned mice
  Effects of SCH23390 on the increase in RyR•-1 and -2 proteins in the frontal cortex and
limbic forebrain in cocaine-conditioned mice were examined. Increased expression of
RyRs was completely abolished by intracerebroventricular pretreatment with SCH23390 at
the dose that blocked the cocaine-induced place preference (Fig. 6). Similarly, the effects
of sulpiride on the increase in RyR-1 and -2 proteins in the frontal cortex and limbic
forebrain in cocaine-conditioned mice was examined. The increased expression of RyRs
was not affected by intracerebroventricular pretreatment with sulpiride at the dose that
blocked the cocaine-induced place preference (Fig. 7).
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Figure 1.
Dantrolene
administered
10 mg/kg).
.t. pÅqo.oOl
#pÅqO.05, ###
cocaine; Dan, dantrolene.
Effect of dantrolene on cocaine-induced place preference in mice.
 (1, 3 or 10 nmol/mouse) or vehicle (V) was intracerebroventricularly
  30 min before subcutaneous treatment with saline (Sal) and cocaine (Coca;
 Each of the data represents the mean Å} S.E.M. obtained from ten animals.
 vs. vehicle-saline group; post hoc Bonferroni multiple comparison test.
PÅqO.OOI vs. vehicle-Cocaine group; post hoc Dunnett's test. Sal, saline; Coca,
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Figure 2. Changes in protein levels of ryanodine receptors in the membrane fractions of
the frontal cortex and limbic forebrain of mice following cocaine-conditioning. FC, frontal
cortex; LF, limbic forebrain; CE, cerebellum. Mice were subcutaneously injected with
saline or cocaine (10 mg/kg) every other day for 6 days After the post-conditioning test,
membrane fractions were prepared from the brains of mice treated with cocaine or saline.
Each column represents the mean Å} S.E.M. of four mice. ""pÅqO.Ol vs. SAL (Student's
t-test). Sal, saline; Coca, cocaine.
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Figure 3. Effects of nifedipine on increased expression of RyR-land-2 jn the frontal
cortex and limbic forebrain obtained from cocaine-conditioned mice. (A) FC, frontal cortex;
(B) LF, limbic forebrain. Mice were subcutaneously treated with saline or cocaine (10
mg/kg) every other day over the period for 6 days. Mice were intracerebroventricularly
infused with vehicle or nifedipine (30 nmol/mouseÅr 30 min before subcutaneous cocaine
(10 mglkg) or saline injection. After the post-conditioning test, membrane fractions were
prepared from brajns of mice treated with cocaine or sajine. Each column represents the
mean Å} S.E.M. of four mice. 'MpÅqO.OOI vs. saline (Bonferroni multiple comparison test).
Veh, vehicle; Sal, saline; Nif, nifedipine; Coca, cocaine.
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Figure 4. Effect of dantrolene on increased expression of ctrt, and ctid subunits of L-type
VGCCs in the frontal cortex and limbic forebrain of cocaine-conditioned mice. (A) FC,
frontal cortex; (B) LF, limbic forebrain. Groups of mice were treated s.c. with saline or
cocaine every other day over the period for 6 days. Mice were lntracerebroventricularly
treated with vehicle or dantrolene (10 nmol/mouse) 30 min before subcutaneous cocaine
(1O mg/kg,) or saline injection. After the post-conditioning test, membrane fractions were
prepared from brains of mice treated with cocaine or saiine. Each column represents the
mean Å} S.E.M. obtained from four mice. "'pÅqO.OOI vs. saline (Bonferroni multiple
comparison test), Veh, vehicle; Sal, saline; Dan, dantrolene; Coca, cocaine.
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Figure 5. Effects of SCH23390 and cocaine-induced place preference in
mice. (A) SCH23390 (3, 10 and 30 nmoVmouse) (B) sulpiride (3, 10 and 30 nmollmouseÅr
or vehicle was intracerebroventricularly administered 30 min before subcutaneous
injection with saline and cocaine (Coca; 10 mg/kg). Each of the data represents the mean
Å} S.E.M. obtained from ten animals. "ftpÅqO.OOI vs. vehicle-saline group (post hoc
Bonferroni multiple comparison test). #pÅqO.05, ###PÅqO.OOI vs. vehicle-Cocaine group
(post hoc Dunnett's test), V, vehicle; Sal, saline; SCH, SCH23390; Sul, sulpiride; Coca,
cocalne.
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Figure 6. Effect of SCH23390 on increased expression of RyRs 1 and 2 in (A) the frontal
cortex and (B) limbic forebrain obtained from cocaine-conditioned mice. FC, frontal
cortex; LF, limbic forebrain. Mice were subcutaneously injected with saline or cocaine (1O
mglkg) every other day over the period for 6 days. Mice were intracerebroventricularly
administered vehicle or SCH23390 (30 nmollmouse) 30 min before subcutaneous cocaine
(10 mg/kg) injection. The membrane fractions used for measuring RyRs were prepared
24 hours after the last conditionjng with cocaine or saiine. Each column represents the
mean Å} S,E,M. of four mice. "'pÅqO.OOI vs. Veh-SAL. ###pÅqO.OOI vs. Veh-Coca group
(Bonferroni multiple comparison test). Veh, vehicle; Sal, saline; SCH, SCH23390; Coca,
cocalne.
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Figure 7. Effect of sulpiride on increase in RyR-1 and -2 proteins in frontal cortex and
limbic forebrain obtained from cocaine-conditioned mice. FC, frontal cortex; LF, limbic
forebrain. Mice were subcutaneously treated with saline or cocaine every otherday for6
days. Intracerebroventricular administration of vehicle or suipiride (30 nmollmouse) was
carried out 30 minutes before cocaine (10 mg/kg, s.c.) injection. The membrane fractions
used for measuring RyRs were prepared 24 hours after the last conditioning with cocaine
or saline. Each column represents the mean Å} S.E.M. of four samples. k"pÅqO.OOI vs.
Veh-SAL (Bonferroni multiple comparison test). Veh, vehicle; Sal, saline; Sul, sulpiride;
Coca, cocaine.
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                               Discussion
   ln the present study, 1 found that a new pathway participating in the cocaine-induced
up-regulation of RyRs, which can lead to the expression of place preference by cocaine, is
regulated by DIDRs. Intracerebroventricular administration of dantrolene, a specific
antagonist for RyRs, significantly suppressed the place preference produced by cocaine,
which is considered to be due to increased expression of RyRs. Indeed, 1 found
significant increases of RyR-1 and -2 in the frontal cortex and limbic forebrain of the
cocaine-conditioned mice, though cocaine-conditioning failed to affect the level of RyR-3
in the frontal cortex and limbic forebrain. In contrast, there were no changes in RyR
levels in the cerebellum, the brain region that does not have an established role in drug
abuse. These data clearly indicate that chronic administration of cocaine changes the
expression of RyRs. These results also suggest that RyR-1 and -2 may be key players in
the development of cocaine-induced place preference.
   Three RyR isoforms have been identified in mammalian tissues, and all of them are
expressed to various degrees in the cNs7'9'i23'i25). until now, it was known that only
RyR-t, known as the skeletal muscle isoform, does not require an influx of extracellular
Ca2' for its activation and that RyR-1 is co--immunoprecipitated with cttc subunit. The
latter provides direct evidence for functional coupling between these two protejns43). That
is, surface membrane depolarization sensed by L-•type VGCCs is transduced to activate
RyR-1. Several studies have reported that dantrolene and nifedipine block the
KCI-evoked increase in Ca2' concentration44). The stimulating effect of KCI on the
increase in intracellular Ca2" concentration presumably results from membrane
depolarization with subsequent activation of L-type VGCCs and associated facilitation of
CtcR from ryanodine-sensitizing Ca2' stores45'46). Because such functional interaction
between L-type VGCCs and RyRs raises a possibility of bidirectional regulatory
mechanisms for their increased expression observed in the cocaine-induced place
preference, 1 investigated such possible mutual regulatory mechanisms. Under the
cocaine-induced place conditioning that significant[y increased RyR-1 and -2 proteins in
the frontal cortex and limbic forebrain, 1 found that i.c.v. pretreatment with nifedipine at the
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dose that significantly blocked the cocaine-induced place preference had no effects on the
increase in RyRs expression. Furthermore, the present study demonstrated that
dantrolene had no potential to modify increased ctic and ctid subunit proteins in the frontal
cortex and limbic forebrain of the cocaine-conditioned mice. These results therefore
suggest that the increased expression of RyRs and cti subunits of L-type VGCCs may be
regulated by independent mechanisms.
  As shown in the present study, the place preference produced by repeated cocaine
injection was significantly suppressed by dantrolene, indicating that the up-regulation of
RyRs participates in the development of the cocaine-induced place preference. In
addition, the blockade of DIDRs and D2DRs by their respective antagonists, SCH23390
and sulpiride, significantly attenuated place preference induced by cocaine. Similar
inhibitory roles of both DlDRs and D2DRs in the development of the place preference of
cocaine have been also reported47'48). These data therefore suggest a possibility that
there may be a functional and/or regulatory pathway between the expression of RyRs
involved in place preference of cocaine and dopamine receptors. As demonstrated in this
study, administration of SCH23390, but not sulpiride, resulted in significant inhibition of the
increased expression of RyR-1 and -2 in the frontal cortex and limbic forebrain evoked by
cocaine, although both dopamine receptor antagonists have the potential to suppress the
cocaine-induced place preference. According to the results shown here, it is reasonable
to conclude that the up-regulation of RyRs is mediated through the activation of DIDRs
during cocaine treatment.
  Although the exact mechanisms of the regulatory effects of DtDRs on RyRs expression
are not clear at present, neurochemical pathway involving cAMP is supposed. Among the
dopamine receptors generally grouped into two subfamilies, Dl-like and D2-like
receptorsi26), D4DRs facilitate cAMP production to activate PKA signaling, which may
finally activate the neurochemical events to up-regulate RyRs. However, the exact
mechanisms remain to be elucidated at present.
   One of interesting findings in this study is that the increased expression of RyRs in the
brains of mice with cocaine-induced place preference is regulated by DIDRs, but not
DIDRs. Although both types of dopamine receptors have the potential to produce the
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cocaine-induced rewarding effect47'48) as well as to mediate reinforcing signals of abuse49),
opposing effects of DIDRs and D2DRs activation on cAMP-dependent signaling have
been reported in many studiesi27). That is, DIDRs activate adenylate cyclase through
stimulatory Gcts protein, and D2DRs inhibit adenylate cyclase via inhibitory God/o protein.
in addition, PKA signaling in the nucleus accumbens is involved in expression of animal
behaviors50-52). Therefore, DIDRs are concluded to be involved in increased expression
of RyRs via cAMP-linked metabolic pathway. However, as demonstrated here, D2DRs
linked to inhibitory pathway of cAMP production have no activity to regulate RyR
expression in the cocaine-induced place preference, which may provide a possible
explanation that D2DRs induce the cocaine-induced place preference through metabolic
pathway different from that activated by DlDRs with increased production of cAMP, though
exact neurochemical pathway that D2DRs facilitate the cocaine-induced place preference
remains to be elucidated.
   The activity of RyRs is modulated by phosphorylation and by associated proteins,
including calmodulin, calsequestrin and FK506-binding proteinsi28'i29). The increased
proteins of RyR-1 and -2 by cocaine-conditioning may be also mediated through the
activation of these associated proteins. However, the regulatory and pathophysiological
roles of these associated proteins including calmodulin, calsequestrin and FK506-binding
proteins in the changes in RyR expression in brain remain to be elucidated.
   Recent investigations also reported nicotine-mediated RyR-2 up•-regulation by CREB in
the VTAii9), and N-methyl-D-aspartate receptors -mediated and L-type calcium channel
activator-mediated increase of RyR-2i20). Furthermore, RyRs are linked to
nicotine-induced neuronal plasticityii9'i2i). These data therefore suggest that the
changes in RyR function may be an important event linking to neurochemical and
behavioral adaptation in association with the alteration of neuronal plasticity occurring in
drug abuse.
  The present study shows the increased levels of RyR-1 and -2, but not RyR-3, in the
frontal cortex and limbic forebrain of mice with cocaine-induced place preference. It is
considered to be difficult to define that cocaine-conditioning fail to affect RyR-3 expression
in the brains of mice with cocaine-induced place preference are specific neurochemical
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events to cocaine-conditioning at present. On the other hand, we have reported that
significant increases of RyR-1 and •-2 in the frontal cortex, significant increases of RyR-1 in
the limbic forebrain, and no changes in RyR--3 in both regions of mice treated with
methamphetamine, which are very similar to those in mice with cocaine-induced place
preference64). Recent investigations also reported nicotine-mediated RyR-2
up-regulation in the ventral tegmental areaii9), and N-methyl-D-aspartate receptors
-
mediated and L-type calcium channel activator-mediated increase of RyR-2 in the rat
hippocampusi20). It has been demonstrated that the modification of expression of RyR-2
and -3 under conditions of cerebral ischemia99). The mouse model of Alzheimer's
disease showed increased RyR-3 expression in cortical neuronsi30). Based on these data,
it is likely that difference in drugs administered and in pathophysiological conditions may
produce different pattern of changes in RyR isoform expression. However, available data
on the exact mechanisms by which isoforms of RyRs are up-regulated under different
pathophysiological conditions are few at present.
  The present study demonstrates that the increase of RyRs in the frontal cortex and
limbic forebrain of mice under intermittent administration of cocaine is significantly
suppressed by a DIDRs antagonist SCH23390, which indicates that the expression of
RyRs is positively regulated by DIDRs. However, as these effects of SCH23390 were
induced by its i.c.v. administration, but not direct injection into the frontal cortex and Iimbic
forebrain, global DIDRs blockade could be produced to modify the functions of reward
circuitry activated during intermittent cocaine administration in any parts of the brain
except of two brain regions described above. Therefore, it is noted that the effect of i.c.v.
injected SCH23390 on RyR expression in the frontal cortex and limbic forebrain
demonstrated here may be due to possible indirect effects mediated through modified
function of other brain regions projecting to the frontal cortex and limbic forebrain, though
such possibility remains to be elucidated.
   In conclusion, the present study demonstrated that repeated treatment of mice with
cocaine increased RyR-4 and -2 levels in the frontal cortex and limbic forebrain, but not in
the cerebellum, which was significantly suppressed by dantrolene. The increased
expression of RyR-1 and -2 in these two brain regions in the cocaine-conditioned mice
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were completely suppressed by the blockade of DlDRs administered prior to cocaine, but
not by D2DRs. These findings indicate that RyR-t and -2 playing a critical role in the
development of cocaine-induced place preference were regulated by DIDRs and that
antagonists of RyRs including dantrolene may be a candidate as possible therapeutics to
treat and/or prevent cocaine dependence.
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                             Chapter 5
Cocaine increases ryanodine receptors via dopamine Dl receptors
97
                               lntroduction
   Previous investigations reveal that RyRs are one of important systems to release
calcium into cytosol from intracellular calcium storesi3i'i32) and that RyRs belong to a
multigene family of channel proteins that mediate intracellular Ca2+ release. RyR
channels contain three subunits with the molecular weight of approximately 560 kDa. All
of three isoforms of RyRs and their mRNAs were detected in the brain, with RyR-2 mRNA
showing the most abundant expression9). Several studies have demonstrated modified
expression of RyRs under neuronal pathophysiological conditions such as
nicotine-mediated plasticityii9} and in mouse model of Alzheimer's diseasei30•i33År.
   In chapter 4, I demonstrated that the increased expression of RyRs is found in the
brain of mouse showing cocaine-induced place preference and this enhancement of the
expression was significantly suppressed by DlDRs blockade, which suggests that RyRs
play a critical role in cocaine•-induced psychological dependence and dopamine receptors
may participate in part in these up-regulation of RyR expression in the brain of mice
showing cocaine-induced place preference. On the other hand, there are few available
reports on RyRs in the brain of mouse with cocaine treatment. The present study
therefore attempts to examine the effects of cocaine on RyR expression using mouse
cerebral cortical neurons in primary culture intermittently exposed to cocaine
98
Materials and methods
Primary culture of cerebral cortical neurons
  Primary culture of cerebral cortical neurons was carried out as described in Chapter 2.
Western btotting
  Western blotting was conducted as described in Chapter 2.
Real-time RT-PCR
   Real-time RT-PCR was conducted as described in Chapter 2.
Immunohistochemistry
  lmmunohistochemistry was carried out as described in Chapter 2,
Materials
  Cocaine hydrochloride was obtained from Shionogi Co., LTD (Osaka, Japan). The
other agents were same as described in Chapter 2.
Statistical analysis
  All data are presented as the mean Å} SEM. Statisticai analysis was carried out using
Prism 5 (Graph Pad). The statistical significance was assessed by the method described
in each figure legend after the application of one-way ANOVA followed by Bonferroni's test
as post-hoc tests.
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RESULTS
Cocaine increased RyRs expression in mouse cerebrat corticat neurons
  The intermittent exposure to cocaine increased the expression of RyR-1 and -2
proteins in a concentration-dependent manner, but showed no effects on RyR-3
expression (Fig. IA). Real-time PCR showed that the intermittent exposure to 10 pM
cocaine significantly increased the level of RyR--1 and -2 mRNA (Fig. 1B). These results
indicate that the up-regulation of RyR-1 and -2 proteins induced by cocaine is due to
increased synthesis of their proteins. Therefore, we further checked the effect of
dopamine blockade on the cocaine-induced increase of RyR-1 and -2 expression using an
antagonist selective to DIDRs, SCH23390. As shown in Fig. 2A, SCH23390
dose-dependently suppressed the cocaine-induced enhancement of both RyR-1 and -2
proteins. Similarly, SCH23390 (10pM) significantly suppressed cocaine•-induced
enhancement of their mRNA (Fig. 2B). Furthermore, we examined a possible
involvement of D2DRs in the cocaine-induced enhancement of RyR-1 and -2 expression.
Sulpiride (10 pM), a selective D2 receptor antagonist, failed to block the cocaine-evoked
enhancement of RyR-1 and -2 proteins (Fig. 3).
lmmunohistochemical characteristics of mouse cerebral cortical neurons
  Representative images of immunoreactivity of TH and DAT in the cerebral cortical
neurons are shown in Figs. 4A and 4B. ImmunoreactMtes for DAT were observed in the
cerebral cortical neurons with high density (Fig. 4B). Double-labeling experiment showed
that DAT was co-localized with TH, a neurochemical maker for dopaminergic neurons, in
the cerebral cortical neurons (Fig. 4C). DAT immunoreactivity appeared to be detected in
the cell surface of TH-positive cells. Immunoreactive for AADC, the second-step enzyme
responsible for conversion of L-DOPA to dopamine was observed in the cerebral cortical
neurons (Fig. 4D). Double-labeling experiment showed that AADC was co-localized with
TH (Fig. 4F). These results clearly demonstrate that dopaminergic neurons are present in
cell population of the cerebral cortical neurons.
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Fig. 1 Effect of intermittent exposure to cocaine on expression of RyR proteins in the
cerebral cortical neurons. (A) The neurons were exposed to cocaine (1, 3 and 10 pM) for
1 h with cultivation in the culture medium without cocaine for following 23 h. Such
protocol to exposure the neurons to cocaine was carried out for 3 days and then proteins
were extracted for measuring RyR expression. The data were obtained from 5 separate
experiments. "P Åq O.Ol, -'P Åq O.OOI vs. control (Bonferroni's test). (B) Effect of
intermittent exposure to cocaine (10 pM) on RyR mRNA expression. The neurons were
intermittently treated with to cocaine and were thereafter subjected to the extraction of
mRNA. The data were obtained from 5 separate experiments. "'P Åq O.OOI vs. control
(Bonferroni's test).
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Fig. 2 Effects of SCH23390 on expression of (A) RyR-1 and -2 proteins and (B) their
mRNA in the cerebral cortical neurons after intermittent exposure to cocaine (10 pM).
The protocol of cocaine exposure was described in the legend of Fig. 1. SCH23390 (O.1,
1 and 10 pM) was added into the culture medium 10 min before cocaine (10 pM) exposure
and then the neurons were exposed to both SCH23390 and cocaine for 1O min followed by
culturing in the absence of both SCH23390 and cocaine for following 23 h. Such protocol
of the exposure to SCH23390 and cocaine was carried out for 3 days and thereafter the
neurons were subjected to extract protein and mRNA. The data were obtained from 5
separate experiments. '-P Åq O.OOI vs. control; ##P Åq O.Ol, ###P Åq O.OOI vs.
cocaine-treated neurons (Bonferroni's test).
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Fig. 3 Effects of sulpiride on expression of RyR-1 and -2 proteins in cerebral cortical
neurons after intermittent exposure to cocaine (10 pM) on expression of RyR-1 and -2
proteins in the cerebral cortical neurons. The protocol of cocaine exposure was
described in the legend of Fig. 1. Sulpiride (10 pM) was added into the culture medium
10 min before cocaine (10 pM) exposure and then the neurons were exposed to both
sulpiride and cocaine for 1O min followed by culturing in the absence of both sulpiride and
cocaine for following 23 h. Such protocol of the exposure to sulpiride and cocaine was
carried out for 3 days and thereafter the neurons were subjected to extract protein. The
data were obtained from 5 separate experiments.
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Fig. 4 lmmunohistochemical characteristics of mouse cerebral cortical neurons. (A)
lmmunostaining of anti--tyrosine hydroxylase (TH) immunoreactivity was shown as red.
(B) lmmunostaining of anti-dopamine transporter (DAT) immunoreactivity was shown as
geen. (C)Feature of merged (A)and (B). In several neurons, TH and DAT are recognized
to be co-localized. (D) lmmunostaining of anti-aromatic-L-amino acid decarboxylase
(AADC) immunoreactivity was shown as red. (E) lmmunostaining of anti-TH
immunoreactivity was shown as geen. (F) Feature of merged (A) and (B). Scale bar: 100
pM.
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DISCUSSION
   This study was carried out for the purpose to define mechanjsms of increase in RyR-1
and -2 proteins using the primary cultures of mouse cerebral cortical neurons intermittently
exposed to cocaine. The present study used the intermittent exposure of cocaine to the
neurons, because mice were usually administered cocaine or other psychostimulants
every two days (three to five times for 6 to 1O days) for conditioning place preference 55).
Therefore, the protocol to expose the neuron to cocaine was defined as used in this study,
which is supposed to resemble that of neurons in the brain of mouse used to examine
conditioned place preference. That is, mice were administered cocaine every two days
for measuring conditioned place preference and the duration of neurons in the brain is
supposed to be exposed to cocaine for approximately 1 h after each administration of
cocaine when considering based on pharmocokinetic profile of cocainet34). Similar
intermittent exposure to amphetamine was indeed used in the previous investigation 66).
Under these conditions, the intermittent cocaine exposed to the neurons increase RyR-1
and -2 proteins, but not RyR-3 protein.
   As demonstrated here the cocaine-induced increase of RyRs proteins was
accompanied with the increase of their mRNA, indicating that the up-regulation of these
receptor proteins is mediated via increased transcription of their genes. DlDRs blockade
with its selective antagonist, SCH23390, dose-dependently suppressed cocaine-induced
up-regulation of RyR-A and -2 proteins. It is noteworthy that the same also completely
inhibited the increased expression of RyR-1 and -2 mRNA. On the other hand, sulpiride,
a selective antagonist for D2DRs, showed no effects on both cocaine-induced increase in
proteins and mRNA of RyR-1 and -2. In addition, immunohistochemical analysis
demonstrated the presence of TH, AADC, and DAT in the neurons. Prevlous reports
demonstrated the presence of both DlDRs and D2DRs in the neurons55).
   These results indicate that cocaine up-regulates RyR-1 and -2 proteins via DIDRs
activation in association with increased induction of their gene transcription and D2DRs is
not functionally coupled with cocaine-induced RyR up-regulation.
   In chapter 4, l demonstrated that biockers for L-type VGCCs, which bind to cti subunits
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of L-type VGCCs to suppress Ca2' entry into cells, inhibit the development of
cocaine-induced place preference, suggesting that the up-regulation of L-type VGCCs
(Ca,1.2 and Ca.1.3 channels) may have a crucial role in the development of
cocaine-induced place preference. Several studies have reported that dantrolene and
nifedipine blocked KCI-evoked increase of intracellular Ca2' concentration44). The
stimulating effect of KCI presumably results from membrane depolarization with
subsequent activation of L-type VGCCs and further CICR from ryanodine-sensitizing Ca2"
store45'46). Although such functional potentiation of intracellular Ca2' dynamics may lead
to the working hypothesis that these increased Ca2' dynamics also bidirectionally
regulates expression of these two types of functional proteins, L-type VGCCs and RyRs,
we reported no effects of nifedipine on the increased of RyR-1 and -2 proteins in the frontal
cortex and limbic forebrain in METH-induced place preference64). These data suggests
that there may be not bidirectinally regulatory mechanisms of expression between these
two types of functional proteins.
   The mechanisms of regulatory effects of DRs on RyR expression are not clear at
present. Cocaine blocks the reuptake of released dopamine by its binding to dopamine
transporter to produce long-lasting rise of synaptic dopamine concentrations i35).
Accordingly, dopamine receptors can be activated for long duration after cocaine exposure.
It has been showed that cocaine-induced increases of many transcription factors and
immediate early genes including CREB, Elk-1 and c-Fos are important for the adaptation of
central nervous system function to cocainei35't36). A lot of evidence suggests that these
changes of gene expression may be mediated through dopamine receptorsi37-i39).
    DRs are generally grouped into two subfamilies, Dl-like and D2-like receptorsi26).
As shown here, DIDRs regulate RyR expression under the conditions with intermittent
cocaine exposure. DIDRs increase cAMP via Gcts protein to activate PKA, one of
cytosolic second messengers including Ca2' and calmodulin kinases, and activation of
PKA in turn phosphorylates CREB to facilitate target gene transcription in heterogeneous
systems and cultured neurons76'77). Therefore, increased expression of proteins and
mRNA of RyR-1 and -2 by cocaine is considered to be induced via such intracellular signal
transduction pathway relating to DIDRs. A recent investigation also reported
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nicotine-mediated RyR 2 up-regulation by CREBi"9). In addition, the role of DlDRs in the
neurochemical and behavioral adaptation induced by amphetamine80'8i) were also
reported. Based on these data it is suggested that cocaine dependence may be caused,
at least in part, by increased RyR-1 and -2 expression via CREB after DlDRs activation.
  Opposing influences of DIDRs and D2DRs activation on cAMP-dependent signaling
have been reported in many studiesi27), DIDRs through stimulatory Gcts protein, and
D2DRs via inhibitory God/o protein. Despite these opposing actions on cellular signaling
via PKA, both DIDRs and D2DRs can mediate reinforcing signals of abuse49). However,
as shown in this study, DIDRs and D2DRs have no potential to regulate the increase of
RyR expression by cocaine, which suggests that the system to inhibit cAMP production by
D2DRs does not play a role in the regulation of RyR expression and may explain why
D2DRs as well as D2DRs can mediate reinforcing signals of abuse49) despite the fact that
D2DRs suppress cAMP production. However, exact mechanisms of different regulatory
effects of DlDRs and D2DRs on RyR expression remain to be elucidated at present.
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                            General Conctusion
   The above findings lead to the following conclusjons (Fig. A):
In Chapter f:
   ln the present study, 1 found that the METH-induced place preference was
dose-dependently suppressed by dantrolene, a RyR antagonist. The levels of RyR-1 and
-
2 in the frontal cortex and RyR-t in the limbic forebrain significantly increased in
METH-conditioned mice. This up-regulation of RyRs were not inhibited by nifedipine.
Both SCH23390 and sulpiride inhibited the development of METH-induced place
conditioning. In contrast, the increases of RyR-1 and -2 in the frontal cortex and of RyR-1
in the limbic forebrain were completely abolished by SCH23390, whereas sulpiride had no
effects. These findings indicate that up-regulation of RyRs is regulated through the
activation of DlDRs in the METH-conditioning.
In Chapter 2:
   lntermittent METH (10 pM, 1 hr/day, for 3 days) exposure enhanced RyR-1 and -2
proteins and their mRNA, but not RyR-3 expression in both types of midbrain and cerebral
cortical neurons. These METH-induced increases of RyR proteins and their mRNAwere
dose-dependently blocked by SCH23390, but not sulpiride, suggesting a regulatory role of
DIDRs in RyR expression by METH in these neurons. In cerebral cortical neurons,
intermittent SKF82958 exposure increased RyR-1 and -2 proteins and their mRNA, while
quinpirole showed no effects. KT5720 dose-dependently attenuated the
METH-stimulated RyR-1 and -2 expression in cerebral cortical neurons. METH
significantly increased phosphorylation of CREB, which was completely suppressed by
SCH23390. These results indicate that RyR-l and •-2 expression is regulated by DlDRs
via the signal transduction linked to DlDRs.
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tn Chapter 3:
   l demonstrated here that the regulation of RyR expression in the VTA of mice showing
METH-induced place preference was mediated vis NMDA receptors. RyR-1 and -2
significantly increased in the VTA of mice with METH-induced place preference, whereas
RyR-3 showed no changes. In addition, the levels of NRI, NR2A and NR2B subunits
were increased in the VTA. The METH-induced place preference was inhibited by
jntracerebroventricular pretreatment with MK-801 and ifenprodil in a dose-dependent
manner. Under these conditions, the increase of RyR-1 and -2 in the VTA was
significantly blocked by ifenprodil. The immunohistochemical analysis revealed the
co-localization of RyR-1 and -2 with NR2B subunjts in dopaminergjc neurons in the mouse
VTA. These findings suggest that RyRs could be involved in the development of
METH-induced place preference and that NR2B subunit-containing NMDA receptors in
mice showing METH-induced place preference play an important role in expression of
RyRs.
In Chapter4:
   The present study investigated the functional role of RyR in mice under intermittent
cocaine treatment using place preference procedure as well as the regulatory mechanism
of up-regulation of RyRs. The cocaine-induced place preference was inhibited by
intracerebroventricular pretreatment with dantrolene, a RyRs antagonist, in a
dose-dependent manner. The levels of RyR-1 and -2 in the limbic forebrain and frontal
cortex significantiy increased in cocaine-conditioned mice, whereas that of RyR-3 in these
two brain regions showed no changes. Although the up-regulation of RyRs was not
affected by blockade of L-type VGCCs, the increase of RyR-1 and -2 in the limbic forebrain
and frontal cortex was completely abolished by SCH23390, a selective antagonist of
DIDRs, but not by sulpiride, a selective antagonist of D2DRs. These findings indicate
that RyRs play a critical role in the development of cocaine-induced place preference and
that the up-regulation of RyRs in the brain of mouse showing cocaine-induced place
preference is regulated by DlDRs, but not D2DRs.
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In Chapter 5:
   This study attempted to investigate regulatory mechanisms of RyR expression using
the cerebral cortical neurons in primary culture intermittently exposed to cocaine.
Intermittent exposure to cocaine significantly enhanced RyR-1 and -2 proteins and their
mRNA, but not RyR-3 expression in the neurons. These cocaine-induced jncreases of
RyR proteins and their mRNA were dose-dependently blocked by SCH23390, but not by
sulpiride. These results confirm the regulatory role of DIDRs in RyR expression in the
presence of cocaine.
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Fig.A scheme of mechanisms of increase in RyRs in the development of METH- and
cocaine-induced psychological dependence. These drugs enhance NMDA-induced Ca2'
response and PKA signaling via dopamine Dl receptor activation, which in turn results in
enhanced CREB phosphorylation. Increase in p-CREB may facilitate transcription factor
                     domain to stimulate RyR synthesis. Such increased RyRsbinding to RyR promoter
elevate intracellular Ca2' concentration via facilitated mobilization of Ca2' from the
intracellular Ca2' stores to the cytosol. On the other hand, up-regulated L-type VGCCs
also work as a stimulator to increase intracellular Ca2' concentration and may futher
enhance CICR via up-regulated RyRs. These changes of intracellular Ca2' dynamics
induced by increased RyRs as we" as L-type VGCCs play an important factor to participate
in the deveiopment of psychological dependence on METH and cocaine.
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